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Abstract 
Osteoarthritis (OA) is a multifactorial disease of the joints with a complex interplay 
between systemic factors, such as age, sex, genetic components, obesity and 
environmental factors (including smoking, diet, physical activity, joint injury and 
muscle function). Among those risk factors, genetic and modifiable factors (obesity) 
have been shown to have a crucial role in the development and progression of the 
disease on radiographs; however, how genetic factors and obesity influence the 
progression of early structures on magnetic resonance imaging (MRI) and its 
symptoms (pain) is not fully understood. This thesis aims to explore how these two 
factors separately or interactively are associated with important structural outcomes 
on MRI and pain. 
Data from two longitudinal studies were utilised (the Offspring and TASOAC study). 
In the offspring study, 372 individuals (186 offspring having at least one parent with a 
total knee replacement (TKR) for severe primary knee OA and 186 controls) aged 
26–61 years (mean age of 45 years) participated at baseline and were followed 2.3 
and 10.2 years later. TASOAC study is a population-based study with 1099 older 
adults aged 50-80 years (mean age of 62 years) enrolled at baseline and followed 
approximately 2.6 and 5.1 years. Cartilage volume, cartilage defects, bone marrow 
lesions (BMLs), meniscal pathology and effusion were assessed by MRI. 
Radiographic OA was assessed by X-ray. Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC) was used to assess knee pain. A self-
reported questionnaire was used to assess pain at neck, back, hands, shoulders, hips, 
knees and feet. Fat mass was assessed using dual energy x-ray absorptiometry. 
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Data from the Offspring study was used to describe the associations of family history 
of knee OA with worsening knee pain and knee structural changes over 10 years. We 
found that offspring had an increased risk of worsening knee pain as compared to 
controls with no family history of knee OA, and this association was independent of 
structural factors. Also, offspring had an increased risk of worsening multiple knee 
structural abnormalities including cartilage defects, meniscal extrusion and tears but 
not BMLs. 
The associations between weight and knee cartilage volume/defects over 10 years in 
offspring and in controls were also examined from the same population. Increasing 
body weight was deleteriously associated with medial tibiofemoral cartilage volume 
and presence of medial tibiofemoral cartilage defects in offspring. Similar 
associations were observed for lateral tibiofemoral cartilage volume and defects. 
However, there were no statistically significant associations between weight and 
cartilage volume or defects in controls. 
The fourth study utilised data from the TASOAC study to explore the associations of 
fat mass, fat mass index (FMI) and body mass index (BMI) with multi-site pain 
(MSP), finding that fat mass was associated with MSP and pain at the hands, knees, 
hips and feet. Results were similar for FMI and BMI. The final study, in the same 
population, found that the presence of MSP independently predicts knee cartilage 
volume loss. 
In conclusion, this series of studies suggest that both genetic and systemic factors 
(especially fat mass) may have an important role in early structural changes and pain 
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in OA, and these two factors interact with each other to involve in the pathogenesis of 
OA. 
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1.1 Overview of osteoarthritis 
Osteoarthritis (OA) is the most common form of joint disease worldwide and is a 
leading cause of pain and impaired function among working age and older adults, 
afflicting 9.6% of men and 18% of women aged more than 60 years [1]. It often 
affects hand and lower extremity joints such as the knee and hip, with an estimated 
lifetime risk for knee OA of being approximately 40% for men and 47% for women 
[2]. The proportion of any doctor-diagnosed OA is estimated to increase from 26.6% 
in 2012 to 29.5% by the year of 2032 in the population aged ≥45 with increasing of 
ageing population, life expectancy and prevalence of obesity [3]. By 2050, it is 
projected that prevalence of OA will increase to 3.14 million Australians or 10.7% of 
the population [4]. 
OA used to be considered as a disorder of the articular cartilage, but it is widely 
recognised that the condition involves the entire joint involving the loss of articular 
cartilage, subchondral bone remodelling, the formation of osteophytes, the 
development of bone marrow lesions (BMLs), thickening of the joint capsule, 
ligamentous laxity, weakening of muscle and meniscal tears and extrusion [5-7]. The 
common symptoms of OA are joint pain related to use, joint stiffness of short-lasting 
inactivity, restricted movement and cracking of joints [8].  
1.2 The impact of OA on health care and its burden  
OA is a highly burdensome condition leading to a large societal and economic 
burden, which is largely attributed to the influences of disability, comorbid disease 
and the expenditure of treatment [9]. It is reported that the cost of care in developed 
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countries accounted for about 1.0% to 2.5% of gross domestic product, and the trend 
of costs was increasing [10]. In United States (US), the total medical expenditures for 
arthritis and other rheumatic conditions increased from $233.5 billion in 1997 to 
$321.8 billion in 2003, most of which were the costs specific to OA [9]. In Australia, 
the fourth largest direct health expenditures ($4.0 billion) in 2004-05 were for arthritis 
and other rheumatic conditions in which OA accounted for nearly one third of total 
expenditures, mainly due to knee and hip replacements [11]. From 2000-01 to 2004-
05, the amount spent on admitted patient services for OA increased by 82% [11]. 
With increasing rate of replacement operations, the health expenditures for OA are 
projected to have a strong upward trend. For instance, the number of knee 
replacement in US and Scandinavia more than doubled between 1999 and 2007-08 
[3]. In addition to health-care related costs of OA, it is very challenging to estimate 
OA-related indirect costs, such as losses of productivity associated with reduced 
employment rate, absenteeism, presenteeism and lost retirement income. Although 
OA is not a life-threatening condition to individuals, it does have a significant impact 
on individuals’ physical and psychological outcomes related to pain, impairment of 
activity, and reduced quality of life [12]. 
1.3 The epidemiology of knee OA 
The knee joint is the most frequently affected site with prevalence increasing with 
age, and it is more common in women than in men [13]. It was estimated that the 
global prevalence of radiographically confirmed symptomatic knee OA was 3.8% in 
2010, and its prevalence arrived at peak at around 50 years old, as shown in Figure 
1-1 [13]. In US and European populations, the prevalence of knee OA with severe 
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radiographic changes is around 1.0% of people aged 25-34 years, but increases to 
about 50% in those aged 75 years and above. The Framingham study reported the 
prevalence of radiographic knee OA increased from 19.2% in those aged over 45 
years to 43.7% in those over 80 years [14]. Furthermore, there are geographical 
variations in the prevalence of knee OA with highest observed in the Asia Pacific 
high-income region [13]. Together with hip OA, knee OA has been ranked as the 11th 
highest contributor of the 291 conditions to global disability. Given the high 
prevalence of knee OA and its crucial role in independent ambulation leading to 
considerable disability preventing knee OA patients participating in society and 
independent living, this thesis mainly focuses on knee OA. 
 
Figure 1-1 1990 and 2010 prevalence of knee osteoarthritis by age, sex, year and 
region, Global Burden of Disease 2010 study [13]. 
Chapter 1 – Introduction 
6 
 
1.4 Diagnosis of OA 
1.4.1 Radiographic OA 
OA is traditionally diagnosed by conventional plain film radiography, with features of 
narrowing of the joint space width, osteophytes formation, the development of 
subchondral sclerosis and cysts [15]. Although radiography is often criticized as lack 
of sensitivity to detecting early stage of disease, lack of specificity to differentiating 
structures of cartilage thickness and meniscus behind joint space width that is subject 
to influence of joint positioning [16], it is still the current standard for evaluating joint 
structures in randomised controlled trials (RCT) of potential disease-modifying 
osteoarthritis drugs (DMOAD) by the regulatory agencies because it is cheap and 
readily available [17]. Lots of attempts have been made to accurately define and grade 
radiographic OA, two scoring systems have been widely using--Kellgren and 
Lawrence (K&L) score [18] and the Osteoarthritis Research Society International 
(OARSI) radiographic altas [19]. K/L system scores OA severity of joint space 
narrowing (JSN) and osteophytes on a scale from 0 to 4 with a cut-off of 2 or greater 
defining definite radiographic OA (Table 1-1); whereas the OARSI altas system 
scores JSN and osteophytes separately and gives a distinct score (Table 1-2). 
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Table 1-1 Definition of the Kellgren-Lawrence radiographic grades (knee) 
Grade Description  
0: No osteoarthritis No features of osteoarthritis 
1: Doubtful Doubtful narrowing of joint space and possible osteophytic lipping 
2: Mild Definite osteophytes and possible narrowing of joint space 
3: Moderate Moderate multiple osteophytes, definite narrowing of joint space and some 
sclerosis and possible deformity of bone ends 
4: Severe  Large osteophytes, marked narrowing of joint space, severe sclerosis and 
definite deformity of bone ends 
 
 
Table 1-2 Osteoarthritis Research Society International altas of radiographic 
features of OA (knee) 
Site and feature Description    
Knee--tibiofemoral     
Marginal osteophytes     
  Medial femoral condyle 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
  Medial tibial plateau 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
  Lateral femoral condyle 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
  Lateral tibial plateau 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Joint space narrowing     
  Medial compartment 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
  Lateral compartment 0 (normal) 1 (mild) 2 (moderate) 3 (severe) 
Other     
  Medial tibial attrition 0 (absent)  1 (present)  
  Medial tibial sclerosis 0 (absent)  1 (present)  
  Lateral femoral sclerosis 0 (absent)  1 (present)  
Chapter 1 – Introduction 
8 
 
1.4.2 Clinical OA 
OA also can be defined clinically by features in the medical history and on physical 
examination. In addition to other clinical features, the presence of joint pain is 
essential to define clinical OA. Currently, the American College of Rheumatology 
(ACR) criteria are the well-recognised standards in the diagnosis of clinical knee [20], 
hip [21] and hand OA [22]. 
1.5 Magnetic Resonance Imaging (MRI) in OA 
Although MRI is not routinely utilised in clinical assessment due to high cost of 
examination, it has become a key imaging tool in OA research considering its 
potential to be more sensitive to detecting earlier disease and structures changes 
which cannot be detected on radiographs, and the capacity to visualise joint structures 
changes in three-dimensional fashion such as cartilage, menisci, BMLs, synovitis and 
effusion [23]. As shown in Figure 1-2, MRI can detect structural abnormities earlier 
than radiography. 
 
Figure 1-2 Osteoarthritis at different stages. 
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Knee cartilage is the most common joint structure measured on MRI. Cartilage 
damage remains the major focus in assessing the development and progression of 
knee OA [24]. The validity, accuracy, reliability and sensitivity of MRI using 
semiquantitative as well as quantitative scoring methods in detecting cartilage damage 
have been well demonstrated [25, 26]. Cartilage volume loss and defects have shown 
their clinical relevance through predicting knee replacements [17, 27-29], but they do 
not have consistent evidence showing their relationships with symptoms (knee pain), 
possibly because of aneural and avascular articular cartilage [30].  
The presence of BMLs is an important feature of knee OA. They can be present in 
those with both early asymptomatic [31, 32] and late-stage knee OA [33, 34]. 
Histologic changes of BMLs consist of bone marrow necrosis (11%), abnormal 
trabeculae (8%), bone marrow fibrosis (4%), bone marrow edema (4%), and bone 
marrow bleeding (2%). BMLs can be evaluated using fluid-sensitive fast spin echo 
sequences with fat suppression (T2-weighted), scored using semiquantitative 
techniques such as Whole-Organ Magnetic Resonance Imaging Score (WORMS) or a 
fully automated method [35, 36]. It has been reported in previous studies that BMLs 
size and score fluctuate in a short time with the possibility of complete resolution [35, 
37, 38]. BMLs in early or advanced disease have been found to be associated with 
cartilage volume loss, progression of cartilage defects in a both short and long time-
frame [31, 39-41], and knee replacement [17, 29, 42-45]. More recently, prior studies 
have shown the relation of BMLs to severity [46], incidence [47] and fluctuation of 
pain [48]. Despite some conflicting results, the evidence supports a relatively 
consistent relation of BMLs to pain [47]. 
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Meniscal damage commonly seen in knee OA is often a result of the increased 
biomechanical loading due to knee malalignment, obesity or injury [49]. Meniscal 
pathology can be viewed and scored by MRI using either quantitative or 
semiquantitative methods [50]. There are two main types of meniscal pathology 
including meniscal tears and extrusion in the semiquantitative method. Meniscal 
pathology is considered an important structural change in knee OA, with significant 
associations between meniscal tears and cartilage loss [50-52], between meniscal 
extrusion and cartilage defects [50-52], and even a predictive role of meniscal 
pathology with knee replacement [17, 29, 42]. However, to date, there is no consistent 
evidence to support their relations to the presence of knee pain [47]. 
Synovitis-effusion is frequently present in knee OA. It is reported that nearly 90% of 
referred knee OA patients have synovitis [53]. Synovitis-effusion can be assessed on 
MRI using quantitative or semiquantitative methods [54]. Currently, non-contrast-
enhanced MRI is often used to measure synovitis-effusion in the research and clinical 
trials due to cost and the potential side-effects of gadolinium, although contrast 
enhancement has an ability to differentiate the thickened and inflamed synovium from 
synovial fluid [17]. Synovitis-effusion assessed on non-contrast-enhanced MRI has 
been shown to associate with increased cartilage defects, BMLs and cartilage volume 
loss [55, 56]. These features also correlate with clinical prognosis and predict knee 
replacement [29]. A moderate association of synovitis-effusion with pain severity and 
pain fluctuation has been consistent in previous studies [57, 58]. So far, a preliminary 
definition in the use of MRI for assessing OA status has been developed, but it still 
needs further validation and testing in the clinical and research setting [59]. 
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In most cases, structural abnormalities detected on MRI are present several years 
before the development of radiographic disease, so targeting these early structural 
changes may prevent OA progression. Cartilage loss is currently considered a 
hallmark of OA, identifying risk factors in those at high risk of developing OA may 
be of particular relevance to OA prevention [60]. With the development of new MRI 
techniques that can identify the compositional changes within these structures, such as 
delayed magnetic resonance imaging of cartilage (dGEMRIC) [61], T2 mapping [62] 
and T1Rho [63], these may advance our outstanding of the role of structural 
abnormalities in the pathogenesis of OA. 
1.6 Risk factors for OA 
It has been recognised that knee OA appears to be determined by a complex interplay 
between systemic factors, such as age, sex, genetic components, obesity and 
environmental factors determined by smoking, diet, physical activity, joint injury and 
muscle function, although the OA’s aetiology is not fully understood [14]. Table 1-3 
summarises the joint-specific risk factors. Environmental factors increasing risk of 
developing OA are mostly related to joint biomechanics in nature and adversely have 
an influence on the joint forces [15, 50]. However, there is increasing evidence that 
most people who have abnormal joint biomechanics do not develop OA, suggesting 
individual susceptibility may be partly determined by systemic factors through 
predisposing individuals to joint injury, causing direct damage to joint tissues, or 
affecting function of repair in damaged joint tissue [14]. Therefore, targeting persons 
with systemic risk factors may allow for the early prevention and diagnosis of OA, 
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such as family history of OA and obesity which are discussed in great details below 
and examined in Chapter 4 and Chapter 5. 
Table 1-3 Risk factors for development of osteoarthritis 
Risk Factor Hip OA Knee OA Hand OA 
Obesity (+) + (+) 
Age + + + 
Female sex  + + 
Genetics + + + 
Smoking    
Physical activity (−) (−)  
joint injury  +  
Muscle    
Grip Strength   + 
Quadriceps  (−)  
+, good evidence increases risk; (+), weak evidence increases risk; blank, inconsistent or no 
evidence of increased risk; (−), weak evidence of protective effect; −, good evidence of 
protective effect. 
1.7 OA-related pain 
Pain is a subjective and complex phenomenon in nature, with the influence of bio-
psychological and social factors [64], which is reflected by definition of pain from the 
International Association for the Study of Pain as “Pain is an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage.” [65]. 
Musculoskeletal pain is very common in general population in western countries 
affecting approximately 13.5-47% of people [66]. Due to high impact on disability, it 
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is a major public health burden [67]. It has been estimated that 30% of American 
adults are afflicted by musculoskeletal pain at any one time [68], and 16% of UK 
adults have pain more than three joints which last more than one week during one 
month [69]. The causes of musculoskeletal pain encompass a spectrum conditions, 
but OA is the most common cause of pain. It is reported that 20% of musculoskeletal 
pain is attributable to OA in Europe [70]. This proportion increases markedly with 
age, with one study showing that 81% and 78% of persons with hand pain and knee 
pain had a definite radiographic hand OA and knee OA [71]. 
1.7.1 Single-site pain (knee pain) 
Knee pain is the prominent symptom of knee OA, which drives individuals to seek 
healthcare, contributes to restrictions in function and reduced quality of life [72]. 
Also, knee pain is main reason for people seeking for joint replacement [72]. 
According to two pain surveys [73, 74], the prevalence of knee pain in older adults 
was estimated about 25%. Furthermore, a United Kingdom (UK) study also reported a 
prevalence of 21% and 35% in men and women aged 45 or above for persistent knee 
pain lasting for at least a week in the previous month [69]. Although some other 
studies estimated a relative lower prevalence of knee pain, these differences can be 
explained by the variation of cases definition, composition of studied population and 
pain questionnaire utilised [75]. 
1.7.2 Multi-site pain 
In pain research, a new concept of ‘multi-site’ or ‘multiple site’ pain has been 
proposed, which means pain occurring at more than one site. Currently, there is no 
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clear definition for multi-site pain (MSP), one definition for chronic widespread pain 
(CWP) based on the diagnostic criteria for fibromyalgia was developed by the ACR 
in 1990 [76]. It requires the presence of pain in the axial skeleton, on the left and 
right, above and below the waist for at least three months. However, in clinical 
reality, there is no cut-off point available in defining MSP [77]. Using definitions of 
widespread pain from ACR often excludes the majority with MSP [78, 79]. It has 
been suggested that counting the number of painful sites could be of particular 
importance and relevance to managing musculoskeletal pain [77].  
There is much evidence showing that people having pain at one site are more likely to 
report pain at other sites concurrently [80-85]. In a study comprising 12,410 adults 
from 18 countries, 41% of people reported pain more than two sites out of six 
anatomical regions [84]. A population-based study in UK showed that three quarters 
of people had pain at two or more sites out of 13 body sites [79]. Two-thirds of people 
having pain in at least two sites of six body sites in the last 12 months were reported 
in a Greek population [86]. Compared to single-site pain, MSP is associated with 
poorer level of physical and psychological health, worse health-related quality of life, 
and more severe depressive symptoms in both cross-sectional and longitudinal studies 
[87-90]. Given more prevalent MSP and more serious impact on health than single 
site pain, pain at one site should not be considered in isolation, but assessment of pain 
at other sites should be stressed. Therefore, the relationship between MSP and 
cartilage volume loss are investigated in Chapter 8.  
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1.7.3 Measure of pain in OA 
In current pain research, there are a number of questionnaires available to assess pain. 
The most common questionnaires include generic unidimensional pain questionnaires 
(Visual Analog Scale and Numeric Rating Scale), generic multidimensional pain 
questionnaires (Short-form McGill Pain Questionnaire, Chronic Pain Grade Scale, 
and Short Form-36 Bodily Pain Scale), and an arthritis-specific pain questionnaire 
(Measure of Intermittent and Constant Osteoarthritis Pain, the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) and the Knee injury and 
Osteoarthritis Outcome Score (KOOS)) [91, 92]. Some other additional 
questionnaires have been developed and validated with consideration of the 
multidimensional nature of pain, such as the Initiative on Methods, Measurement, and 
Pain Assessment in Clinical Trials [93] and Patient Reported Outcomes Measurement 
Information System [94]. Despite that these questionnaires have been widely used for 
pain assessments, each questionnaire has its own strengths and weakness. As a result, 
it is impossible that complex pain experience with variation in pain intensity, 
frequency, pattern and quality can be adequately captured by a single existing 
questionnaire. Furthermore, differences in use of questionnaires in OA research may 
result in the variation in reported pain prevalence. Question about presence of pain 
over a specified period (e.g. “pain on most days of a month in the past year” vs “pain 
on most days of the past month”) of time may be prone to recall bias [95]. Also, 
simple pain questionnaires current studies have been using are insufficient to allow 
complex interactions to be ascertained, this might be one of possible explanations for 
poor correlations between structures and pain in OA. Other than pain intensity, pain 
questionnaire should keep with the acknowledgment of the multidimensional nature 
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of pain with the consideration of physical functioning, socio-psychological 
functioning, as well as other domains such as fatigue, sleep, and cognition. However, 
to date, there is no pain questionnaire available in this kind. Pain questionnaire should 
be improved and refined in future. 
1.7.4 Structural damage and OA-related pain 
Pain in OA has been considered nociceptive pain, arising from stimulation of 
peripheral local tissue damage [96]. Cartilage, the primary site of OA pathology, is 
aneural and avascular, so cannot generate pain directly, raising the possibility that 
pain may come from other structures [96]. By contrast, subchondral bone, adjacent 
periosteum, synovial membrane, periarticular ligaments and joint capsule are richly 
innervated with the nerve fibres transmitting peripheral input to spinal cord [8]. 
However, imaging studies have widely reported a significant discordance between 
radiographic severity of OA and knee pain [72]. A systemic review of literature 
concluded that 15-76% of patients with knee pain had radiographic OA, and 15-81% 
of patients with radiographic OA had knee pain [97]. This discordance is often 
explained by the ability to discern underlying pathologies contributing to pain [57]. 
As stated above, in light of the ability of visualising detailed structures on MRI, some 
studies have examined the relationships between structures on MRI and knee pain, 
and reported inconsistent results [57]. This is supported by a recent literature review 
concluding only thirteen of twenty-one studies reporting statistically significant 
associations of MRI findings in OA and symptoms [98]. Table 1-4 summaries the 
associations between structures detected on MRI and knee pain. Overall, the levels of 
evidence between structural features and pain are limited or conflicting, except for 
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BMLs and effusion-synovitis which appear to have a moderate levels of evidence 
supporting their relation to OA-related pain [72]. Lack of strong evidence of the 
associations between structures detected on MRI scans or radiographs suggests that 
pain may be mediated by other factors, such as genetic components, and there may be 
a central component to pain [99]. 
Table 1-4 Associations between knee structural factors detected by MRI and 
pain 
Structures 
Evidence 
No Conflicting Limited Moderate Strong 
Cartilage defects  +    
Meniscal pathology  +    
Bone marrow lesions    +  
Bone attrition  +    
Osteophytes   +   
Effusion-synovitis    +  
Ligament tear   +   
Tibial bone size +     
The levels of evidence were using best evidence synthesis based on the guidelines on systematic 
review of the Cochrane Collaboration Back Review Group [100]. 
1.7.5 Pain mechanisms in OA 
Various studies have also shown pain in OA is neuropathic, reflecting that the 
potential mechanisms of neuropathic pain is a consequence of the interrelation of 
peripheral and central sensitisation mechanisms [101-103]. Joint injury and/or 
inflammation lead to the release of mediators into the joint which sensitize primary 
afferent nerves with a reduction in threshold and an amplification of responsiveness to 
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suprathreshold stimuli of peripheral nociceptors (peripheral sensitisation) [104-106]. 
As such, exaggerated responses to noxious mechanical stimuli (primary hyperalgesia) 
can be evoked, and normally innocuous joint movement can evoke a painful response 
(allodynia) [72]. Increased peripheral neuronal activity further confers the alteration 
in pain processing by central nervous system (central sensitisation) including more 
responsive to peripheral input, an expansion of receptive filed of dorsal horn neurons 
as well as brain activation, sensitisation and modification [99, 107]. Studies using 
quantitative sensory testing (QST) analyses and functional MRI have confirmed 
central sensitisation in OA [103, 107]. The presence of central sensitisation in OA 
may be predictive of more severe, longer duration and larger area pain which cannot 
be treated by conventional analgesics [102] and is a possible explanation for pain 
occurring at multiple sites. 
1.7.6 Risk factors for OA-related pain  
Pain is a very complex process affected by multiple interactive pathways including 
genetic, environmental, socio-economic and psychological factors [108]. Risk factors, 
such as environmental and psychosocial factors for single-site pain, have been 
extensively investigated in previous epidemiology studies, although the potential 
mechanisms of these factors contributing to pain are not yet well understood. At 
present, genetic contribution to OA-related pain is far less to know as comparing to 
genetics in OA. Furthermore, most of previous studies have exclusively focused on 
single-site pain and thought that risk factors identified is exclusive to each pain site, 
leading to uncertainties as to whether risk factors for MSP are different from single-
site pain. Due to the importance of genetic factors and obesity in OA, it is possible 
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that understanding these two factors in OA-related pain is also relevant to clinical 
practice in the diagnosis and treatment of OA. Therefore, this thesis is focusing 
genetic factors in OA-related pain (Chapter 6) and modifiable factors (obesity) in 
MSP (Chapter 7).  
1.8 Treatment and management of OA and pain 
Increased understanding of the pathogenesis of OA and its symptom (pain) allows the 
ability of identification of ‘at risk’ patients, diagnosis of early OA and evaluation of 
the efficacy of treatment within a short period. There are some new therapeutic 
interventions proposed and conducted in clinical trials with several drugs as disease 
modifying agents in OA, such as chondroitin and glucosamine; however, no 
therapeutic interventions to modify the structures and improve symptom concurrently 
have been approved so far [15]. Currently, therapeutic interventions for OA are 
palliative and primarily focus on alleviating pain [2]; however, treatment for the 
management of OA pain is problematic and mainly targets peripheral joint and 
peripheral nervous system. Non-steroidal anti-inflammatory drugs (NSAIDs) have 
been a mainstay treatment for OA pain [109], but the efficacy of these has been 
proven to be only moderate with more than 75% of symptomatic OA patients 
reporting need for additional symptomatic treatment [110]. Intra-articular 
glucocorticoid injections and joint replacement surgery also play a key part in the 
management of OA, both targeting peripheral mechanism of pain [111, 112]. Failure 
to relieve OA pain through these treatments is frequently seen in the clinical settings; 
for instance, there are approximately 7-23% and 10-34% of patients having long-term 
pain after hip and knee replacement surgery [113, 114], suggesting that treatments 
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targeting peripheral mechanisms are insufficient for those patients. Hence, for those 
patients, targeting central pain processing may be more beneficial. An increasing 
number of drugs with central actions are also under investigation, such as duloxetine 
which has been approved by US food and drugs administration for the treatment of 
musculoskeletal pain [115]. 
Instead, modifiable risk factors (primarily obesity) have been a focus in the treatment 
and management of OA and pain especially when there is absent of pharmacologic 
agents that can modify disease. Good evidence is that weight loss in obese patients 
can reduce the risk of the development of symptomatic OA [116] and improve 
symptoms in OA patients [117]. Despite lack of radiographic structural modification 
through weight loss, it has been shown that weight loss has structure-modifying 
effects for obese individuals in morphological and physiological MRI [118] and 
significantly reduces low-grade systemic inflammation [119]. A combination of 
exercise and diet is recommended for weight management [120]. Benefits of exercise 
are evident with increase in muscle strength and aerobic capacity, [121], and with 
cardiovascular health and all-cause mortality [15], but the effects of exercise need to 
further elucidated. Some of other therapeutic options are available to help modify 
joint forces including knee braces, orthotics, patella taping and knee osteotomies 
[122]; however, in general, there is limited evidence for the effectiveness of these 
therapeutic interventions. 
1.9 Genetic factors in OA 
OA has been shown to be affected by a considerable underlying hereditary 
component, although it was considered a disease of age-related wear-and-tear on the 
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cartilage of the affected joint [123]. The initial search for genetic components of OA 
started from observational studies -- twin pair, sibling risk and segregation studies 
which found an increased risk of the development of OA in the relatives of patients 
with Heberden’s nodes [124] or hip OA [125], and the siblings of prohands 
undergoing total joint authroplasty [126]. Heritability estimated from previous studies 
has shown that 39–65% of the risk of developing OA can be explained by genetic 
components, which appears to be stronger in hip and hand OA than in knee OA, and 
varies depending on gender and severity of the conditions [127, 128]. This early 
evidence stimulated a considerable genetic search for genetic loci responsible for the 
susceptibility to OA. In 1990, Prockop et al. [129, 130] reported the first gene 
(COL2A1), which encodes for the alpha 1 polypetide chain of type II collagen, the 
principal collagenous component of articular cartilage, and that the mutation of this 
gene gives rise to impaired the matrix and premature degeneration of the cartilage.  
In the past few decades, a number of candidate-gene studies have been conducted 
with few positive results replicated in the different populations [131]. Most of studies 
reported the false positive results possibly because of small sample sizes and lack of 
adjusted P values in reporting of significant results. Currently, there is one exception 
in candidate-gene studies in which rs143383 in the growth differentiation factor 5 
(GDF5) gene showed a robust and significant association with OA across different 
populations with a genome-wide significance (P<5×10-8) [132]. With the advent of 
high throughput single nucleotide polymorphisms (SNPs) genotyping technology, it 
makes genome-wide association scans (GWAS) possible with hundreds of thousands 
of SNPs concurrently tested for association with disease. Currently, there are multiple 
loci identified from GWAS contributing to the susceptibility to the development OA 
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[133]. Table 1-5 lists the established loci with genome-wide significance in OA 
research. Although these studies further provided firm evidence of genetic component 
in OA, there is no single loci individually and substantially conferring increased risk 
of developing OA as comparing to autoimmune rheumatic diseases in which a 
significant influence of the major histocompatibility complex (MHC) region is 
involved in its susceptibility [134]. As shown in Table 1-5, the majority of odds ratios 
were less than 1.2, suggesting that a small effect of each individual allele determines 
the susceptibility to OA. Furthermore, significant joint-specific effects of genetic 
components were observed. Few loci have been found to have associations in both 
European and Asian populations with distinct ethnic differences in genetics, but the 
reason for these differences are still not clear. One of limitations of GWAS is that 
common variants, defined as frequencies >5% of the population are best assessed 
with limited ability to detect rare variants [128]. Another limitation is stringent 
statistical significance threshold; this therefore needs large sample sizes or very large 
genetic effects [128]. 
OA is a highly heterogeneous disease with variable clinical features. At present, there 
is no consensus on the definition of OA cases in current genetic studies; some centres 
used clinical or radiographic definitions whereas others used total joint replacement 
(TJR). These definitions cannot consider early changes of the disease in which 
different determinants may be involved, and thus further complicating the search for 
susceptibility alleles [123]. Therefore, standardised OA phenotypes are urgently 
needed in future genetic studies. More subtle structural changes visualised on MRI is 
increasing our understanding of the disease, so a possible solution is that using early 
structural abnormalities on MRI as phenotypes of OA may enable study of the genetic 
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influences on OA better when no consensus definition of OA is available currently. 
Although evidence of a genetic predisposition to OA is ample, far fewer have been 
identified with OA progression. Genetic factors in the progression of early structural 
changes on MRI are examined in the Chapter 4. It is likely that genetic factors 
related to the onset of the disease may also promote its progression; however, there is 
sparse evidence to support these relationships.  
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Table 1-5 Established loci with genome-wide significance in OA research (from Panoutsopoulou K et al. [133]) 
SNP Nearest* gene(s) EA EAF OR, 95% CI p Value Site Sex Ethnic group Source 
rs143383† GDF5 T 0.74 1.79, 1.53 to 2.09 2×10−13 Hip Both Asian [135] 
rs143383† GDF5 T NA 1.16, 1.11 to 1.22 8.3×10−09 Knee Both European [132] 
rs7639618 DVWA G 0.63 1.43, 1.28 to 1.59 7.3×10−11 Knee Both Asian [136] 
rs7775228‡ HLA-DQB1 T 0.62 1.34, 1.21 to 1.49 2.4×10−08 Knee Both Asian [137] 
rs10947262‡ BTNL2 C 0.58 1.31, 1.20 to 1.44 5.1×10−09 Knee Both Asian and European [137] 
rs3815148§ COG5¶ C 0.23 1.14, 1.09 to 1.19 8×10−08 Knee and hand Both European [138] 
rs4730250§ DUS4L¶ G 0.17 1.17, 1.11 to 1.24 9.2×10−9 Knee Both European [139] 
rs11842874 MCF2L A 0.93 1.17, 1.11 to 1.23 2.1×10−08 Knee and hip Both European [140] 
rs6976** GLT8D1†† T 0.37 1.12, 1.08 to 1.16 7.2×10−11 Hip and knee Both European [141] 
rs11177** GNL3†† A 0.38 1.12, 1.08 to 1.16 1.3×10−10 Hip and knee Both European [141] 
rs4836732 ASTN2 C 0.47 1.20, 1.13 to 1.27 6.1×10−10 Hip Females European [141] 
rs9350591 FILIP1; SENP6 T 0.11 1.18, 1.12 to 1.25 2.4×10−09 Hip Both European [141] 
rs10492367 KLHDC5; PTHLH T 0.19 1.14, 1.09 to 1.20 1.5×10−08 Hip Both European [141] 
rs835487 CHST11 G 0.34 1.13, 1.09 to 1.18 1.6×10−08 Hip Both European [141] 
rs12107036 TP63 G 0.52 1.21, 1.13 to 1.29 6.7×10−08 Knee Females European [141] 
rs8044769‡‡ FTO C 0.5 1.11, 1.07 to 1.15 6.9×10−08 Hip and knee Females European [141] 
rs10948172 SUPT3H; CDC5L G 0.29 1.14, 1.09 to 1.20 7.9×10−08 Hip and knee Males European [141] 
rs6094710 NCOA3 A 0.04 1.28, 1.18 to 1.39 7.9×10−9 Hip Both European [142] 
rs12982744 DOT1L C NA 1.17, 1.11 to 1.23 7.8×10−9 Hip Males European [143] 
*Nearest gene(s) only shown. 
†Summary statistics of the same SNP in separate studies in Asians and Europeans, respectively. 
‡SNPs in strong linkage disequilibrium. 
§SNPS in strong linkage disequilibrium. 
¶chr7q22 locus encompasses more genes than shown here, for full details see Kerkhof et al. [138] and Day-Williams et al.[140] 
**SNPs in strong linkage disequilibrium. 
††chr3p21.1 locus encompasses more genes than shown here, for full details see arcOGEN Consortium.[141] 
‡‡This signal was attenuated after BMI adjustment, suggesting that the FTO locus exerts its effect on OA through obesity. 
BMI, body mass index; EA, Effect allele; EAF, effect allele frequency; OA, osteoarthritis; SNP, single nucleotide polymorphism.
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1.10 Obesity/inflammation in OA 
Obesity has become a serious public health issue worldwide over the past several decades. It 
affects all population and all age groups, resulting in extensive morbidity and mortality [144]. 
In Australia, the prevalence of overweight and obesity has been steadily rising for the past 30 
years. A survey conducted in 2011-2012 reported that around 60% of Australia adults were 
classified as overweight or obese, more than 25% of whom were obese [145]. This upward 
trend imposes substantial obesity-related chronic diseases, including OA, and economic 
burdens.  
The association between obesity and OA has been well-established in prior cross-sectional 
and longitudinal studies [146], with relatively stronger associations with knee OA than with 
hip OA [147]. Being overweight or obese is not only associated with the onset of OA [148], 
but also with an increased risk of OA progression [2]. A recent meta-analysis including 25 
cohort studies by Silverwood et al. [139] showed a 2.1-fold increased risk of knee OA in 
overweight or obese individuals. A dose-response relationship between obesity and risk of 
knee OA has been demonstrated from a meta-analysis with 35% increased risk of knee OA 
being associated with every 5-unit increase in body mass index (BMI) [149]. Furthermore, 
studies examining associations between obesity and early structural changes on MRI have 
shown a deleterious effects of obesity or overweight on knee cartilage [150] and subchondral 
bone [151]. There were more consistent detrimental relationships between increasing weight 
or BMI and cartilage defects than that with cartilage volume [150]. Also, increasing BMI and 
weight have been found to be associated with increased prevalence of BMLs in both 
asymptomatic [31, 152, 153] and symptomatic populations [38]. Conversely, weight loss has 
shown a decreased risk for developing knee OA [154] and worsening early structures [150], 
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and vice versa [155]. Taken together, the findings from previous studies suggest that 
increased weight or BMI may play a crucial role in early stage of the disease. 
The mechanisms underlying the link between obesity and OA are complex. Joint loading has 
been considered an important role in this relationship; however, obesity not only confers an 
increased risk of weight-bearing joints, but also an increased risk of hand OA, indicating joint 
loading cannot completely explain its effects on OA, and raising the possibility that obesity 
may exert its effects on OA through metabolic and systemic inflammation [156, 157]. Indeed, 
adipokines, such as leptin, have been linked with the initiation of OA [158]. In animal model, 
obesity did not induce the development of OA in the absence of leptin. Consistently, an 
earlier study from our group found a reduced cartilage volume loss with elevated serum 
levels of leptin [159]. Our group also reported that serum levels of interleukin-6 (IL-6) and 
tumor necrosis factor-α (TNF-α) are associated with knee cartilage volume loss [160], 
although the role of cytokines in the pathogenesis of OA remains to be elucidated [161, 162]. 
As stated above, OA is a heterogeneous condition as a result of a complex interaction 
between systemic and environmental factors. In some cases, the presence of genetic 
abnormality alone may not increase risk of OA, that is, it interacts with other environmental 
elements, such as obesity, contributing to risk of OA. It is possible that structural 
abnormalities caused by genetic factors creates an at risk environment, predisposing 
individuals to increased influence of environmental factors termed gene-environment 
interaction [163, 164]. Given strong genetic components and obesity underlying the 
pathogenesis of OA, understanding the interaction between genetics and obesity better will 
aid the prevention of OA. Their interactions are examined in the Chapter 5 
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1.11 Genetic factors in OA pain  
Robust inter-individual differences in pain experience are often observed in the clinical 
sitting, raising the possibility that inter-individual variability in the experience of pain may be 
due to differences in pain sensitivity which is probably affected by underlying genetic factors 
[165]. Earlier twin and epidemiological studies have demonstrated that pain sensitivity per se 
is heritable [166, 167], although it has been suggested that a range of factors such as prior 
experience, expectation, and current mood modulate experience of pain and these factors 
themselves are genetically mediated [168-171]. The estimates of heritability from studies 
range from 9% to 60% for different pain traits [168, 169, 172]. The heritability of knee pain 
was estimated about 44% in a sib-pair study from our group [173]. 
With regard to these findings in prior studies, research has been trying to search for genes 
that might predispose individuals to development of chronic pain or experiencing greater pain 
sensitivity. There were two categories (linkage and candidate-gene studies) that the majority 
of studies have fallen into. A variety of genes identified have been shown to be tentatively 
associated with pain states [174, 175]. Like in other fields, there have been inconsistent 
associations in the replication across populations or across pain conditions. Other than the 
general reason for inconsistent results in genetic studies including sample size, pain 
definition, etc, the pain field struggles with the existence of complex pain phenotypes [174]. 
For example, pain conditions are quite heterogeneous even if one could identify genetic 
associations with specific pain conditions, such as low back pain, or there are a number of 
subcategories while investigating a broader category of clinical pain [165, 174]. Recent years 
have seen an explosion of GWAS in the identification of risk alleles; however, GWAS in 
human pain has lagged behind than in other fields, for reasons such as difficulties in 
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undertaking the quantitative phenotyping of this subjective phenomena [176]. At present, 
there is only one adequately powered GWAS conducted for CWP [177]. 
Relative to numerous genomics studies in OA, only few studies have examined genes that 
regulate OA-related pain so far. Currently there are five genes identified with a possible 
association with pain in OA, as shown in Table 1-6. A common genetic variant of Val158Met 
in catechol-O-methyltransferase (COMT) gene which reduces the activity of the 
catecholamine degrading enzyme was identified to be associated with hip pain among those 
with hip OA [178]. Unfortunately, this SNP failed to be replicated for knee pain in an 
independent and adequately powered study [179]. Another gene SCN9A encoding the voltage 
gated Sodium Channel 1.7 (Nav1.7) that is essential for transmission of pain-related signals, 
was initially shown to associate with higher pain reports in a study with 578 OA patients 
[180], and held up in a larger cohort of replication study [181]. Some other candidate genes 
have been examined and have confirmed associations with OA-related pain, including 
transient receptor potential cation channel subfamily V member 1 (TRPV1), P2X7 and 
proprotein convertase subtilisin/kexin type 6 (PCSK6). No studies have investigated genetic 
factors in the pain evolution, and which genes can explain evolution in clinical and 
experimental pain responses. Chapter 6 examines the effect of OA family history on 
worsening knee pain. Identifying genetic variants in a genetically enriched cohort may 
facilitate the stratification of population and our understanding of this extremely 
heterogeneous disorder. 
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Table 1-6 Genomics studies in osteoarthritis-related pain 
Studies SNP Gene Protein Function of protein Sample size (n) 
Sex 
(%) 
Ethnic group Source 
Initial study†         
 rs4680 COMT Catechol-O-methyltransferase 
Degradation of catecholamine 
neurotransmitters such as norepinephrine 
and dopamine 
288 (radiographic hip OA) 59 Caucasian [178] 
     171 (female radiographic hip OA) 100 Caucasian  
 rs6746030 SCN9A 
Voltage gated Sodium 
Channel 1.7 (Nav1.7) 
Nociception signalling 578 (symptomatic OA) 64 Caucasian [180] 
 rs8065080 TRPV1 
Transient receptor potential 
cation channel, subfamily V, 
member 1 
Transducer of painful thermal stimuli 
7122 (3270 symptomatic knee OA 
and 3852 controls) 
63 Caucasian [182] 
     
4950 (1098 asymptomatic knee OA 
and 3852 controls) 
70 Caucasian  
 rs7958311 P2X7 P2X7 purinoceptor 
ATP receptor-transducer of pain with 
neuropathic and inflammatory origin 
1329 (743 symptomatic OA and 
586 controls) 
58 
Caucasian and 
African American 
[183] 
 rs900414 PCSK6 
PACE4 (paired amino acid 
converting enzyme 4) 
Activating pro-aggrecanases 
3634 (2068 symptomatic knee OA 
and 1566 controls) 
60 Caucasian [184] 
     
2240 (674 asymptomatic knee OA 
and 1566 controls) 
66 Caucasian  
Replication rs4680 COMT Catechol-O-methyltransferase 
Degradation of catecholamine 
neurotransmitters such as 
norepinephrine and dopamine 
9556 (3934 symptomatic knee OA 
and 5622 controls) 
62 Caucasian [179] 
     
6781 (1159 asymptomatic knee OA 
and 5622 controls) 
65 Caucasian  
 rs6746030 SCN9A 
Voltage gated Sodium 
Channel 1.7 (Nav1.7) 
Nociception signalling 
1854 (1325 symptomatic OA or 
TKA and 529 asymptomatic OA) 
47 Caucasian [181] 
†Studies reported significant associations between genes and pain; 
OA osteoarthritis; TKA total knee arthroplasty.
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1.12 Obesity/inflammation in OA pain  
Since the end of last century, the relationship between obesity and chronic pain has 
attracted extensive investigations. There is a sizeable evidence to suggest that obesity 
and pain adversely impact each other, and obesity is predictive of worse functional 
and psychological status of chronic pain [185]. Based on a recent US study in one 
million people, individuals with overweight (BMI, 25–29.9 kg/m2) reported 20% 
higher rates of pain, 68% higher for those BMIs of 30–34 kg/m2, 136% higher for 
those BMIs of 35–39 kg/m2 and 254% higher for those BMIs of more than 40 kg/m2 
compared to normal weight group [186]. Evidence from longitudinal studies suggests 
that obesity is an important risk factor for the development of chronic pain, indicating 
that obesity is more likely a cause rather than a consequence of pain [187-189].  
It has long been assumed that potential mechanism underlying the relationship 
between obesity and pain may be due to mechanical loading, especially for lower 
extremities. There is a linear increment of compressive loading across the joint as 
BMI increases. In knee OA, relative to those with overweight, people classified as 
class 1 or 2+ obesity have greater peak knee compressive forces [190]. Similarly, 
weight loss has been shown to be effective in reduction of knee joint forces [191]. 
Increased joint forces may result in aberrant biomechanical environment; it is, 
therefore, not surprising to observe greater structural damage in the loading joint in 
obese individuals, as mentioned above. The evidence of the role of inflammation 
involved in the link between obesity and pain is accumulating because adipose tissue 
has been recognised as an endocrine organ responsible for producing and releasing 
proinflammatory cytokines and adipokines [192]. Research shows an increased level 
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of cytokines and inflammatory markers, such as C-reactive protein (CRP), IL-6, TNF-
α and leptin in obese individuals [193, 194]. In addition, the release of inflammatory 
markers also can be triggered by the breakdown products from structures or tissues 
damages due to aberrant loading [195, 196]. Elevated levels of these biomarkers lead 
to enhancing pain severity and its change [197, 198] which in turn stimulate more 
inflammatory markers release [199]. It has been suggested that inflammation can lead 
to a lowering of excitation threshold and enhanced responses to suprathreshold stimuli 
of peripheral nociceptors (peripheral sensitisation) and subsequently developing 
central nervous system sensitisation with pain hypersensitivity and increased 
vulnerability to reporting more pain sites [72, 200]. In this context, research should be 
expanded to investigate the relationship between inflammatory markers and MSP; fat 
mass could be an ideal surrogate as a source of inflammatory markers in 
epidemiological studies. Chapter 7 investigates the relationship between fat mass and 
MSP. Furthermore, in OA, one constant question for researchers and clinicians is 
whether pain is an early marker for early OA, albeit with conflicting results of 
associations between structural damages and single-site knee pain as stated above. It 
is worth investigating the relationship between MSP and structural damage as MSP 
may represent a higher level of inflammation and dysfunction in central pain 
processing, see more details in Chapter 8.  
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Research questions 1, 2 and 3 investigate family history of knee OA and its 
interaction with body weight on knee structural changes and knee pain. 
In a prospective cohort study with offspring having at least one parent with total knee 
replacement (TKR) for severe primary knee OA and controls with no family history 
of knee OA examined at baseline, 2.3 and 10.2 years later: 
1. What is the relationship between family history of knee OA and knee structural 
changes over 8-10 years? 
1.1. Do offspring have greater knee structural changes including cartilage defects, 
meniscal tears, meniscal extrusion and BMLs as compared to controls? 
2. Is there a difference in the relationship between body weight and knee cartilage 
volume loss and defects in offspring and controls? 
2.1. Does body weight in the offspring have a more detrimental effect on knee 
cartilage than in controls?  
3. What is the relationship between family history of knee OA and changes in knee 
pain over 8 years, as measure by the Western Ontario and McMaster University 
Osteoarthritis Index (WOMAC) questionnaire? 
3.1. Do offspring have an increased risk of worsening knee pain? 
3.2. Is the relationship between family history of knee OA and changes in knee 
pain dependent of knee structural factors? 
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Research questions 4 and 5 investigate obesity on MSP and the predictive value of 
MSP for the hallmark of knee OA (cartilage volume loss). 
In a population-based cohort of aged 50–80 years examined at baseline and 2.6 and 
5.1 years later: 
4. What are the associations between fat mass, fat mass index and body mass index 
and MSP over 5.1 years? 
4.1. If there is any association, what is the potential mechanism underlying the 
association? 
5. What is the association between MSP and knee cartilage volume loss over 2.6 
years? 
5.1. Do people having more painful sites have greater cartilage volume loss? 
5.2. Which mechanism mediates the association? 
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3.1 Preclude 
This thesis utilised the data from the Offspring study and Tasmanian Older Adult 
Cohort (TASOAC) study in which a number of outcome factors, exposure factors and 
covariates have been used. The former was used for Chapter 4, 5 and 6; the latter one 
Chapter 7 and 8. In these chapters, the study design, study population as well as 
measurement protocols of studied factors which are common to these two studies are 
described below. For those studied factors which are unique to each chapter and 
covariates, the descriptions of those factors are given in details in the corresponding 
methodology section of the following chapters. 
Please be aware that the following chapters are presented in the form in which they 
were accepted by peer-reviewed journals. Therefore, there might be some differences 
in the description of methods in accordance with requirements of those journals and 
requests from journal reviewers. The sample sizes for different chapters vary and are 
determined by available data for studied factors of the research questions. 
3.2 Study population and design 
3.2.1 Offspring study 
The Offspring Study is a population-based case control study with longitudinal 
follow-up over ten years. Cases (N=186, mean age 45 years) were enrolled from the 
eligible adult offspring of subjects who have had TKR performed for primary OA of 
the knee in Hobart in 1996-2000. Age- and sex-matched controls (N=186) were 
randomly selected from the electoral roll. People were qualified to be included on the 
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roll if they were: (1) 18 years of age or older, (2) an Australian citizen, (3) an elector 
entitled to vote at a house of representatives election or qualified to become such an 
elector. Disqualified from the roll were those who were (1) a member of a state or 
territory parliament, (2) a citizen or subject of a foreign power, (3) serving a prison 
sentence of 12 months or more, (4) an undischarged bankrupt or insolvent, (5) holding 
an office of profit under the Crown (e.g. Public Servant), or (6) a permanent member 
of the Australian Defence Force. They amounted to about 15% of residents. 
Participants from either group were also excluded on the basis of contraindication to 
MRI (including metal sutures, presence of shrapnel, iron filing in eye, and 
claustrophobia).  
The initial measurements were taken from June 2000 to December 2001, a total of 
372 participants (186 offspring and 186 controls) aged 26 to 61 years  were enrolled. 
The Phase 2 was conducted 2.3 years (range: 1.8–2.6 years) later, 326 participants 
(162 offspring and 164 controls) were traced. The Phase 3 was conducted at 10.2 
years (range: 9.1–11.4 years), 219 participants (115 offspring and 104 controls) were 
included. 
3.2.2 TASOAC study 
The TASOAC is a longitudinal, observational population-based study. The cohort 
consisted of both men and women and was selected from the electoral roll in Southern 
Tasmania generated by staff of the Tasmanian Electoral office (total number of 
people on the roll n=229,593) using sex-stratified simple random sampling without 
replacement. The eligible cohort consisted of registered electors aged 50–80 years 
(n=61,715, men/women=29,484/32,231). Institutionalised older adults were excluded 
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because TASOAC was designed to study community-dwelling older adults. 
Participants were also excluded if they had contraindications for MRI (including 
pacemakers, implants and claustrophobia), as these tests were required to examine 
OA progression.  
Figure 3-1 shows an overview of subject recruitment and withdrawal during the study 
period. A total of 2,530 subjects were selected from the roll using 5-year age band 
information with equal number of men and women. Among them, 395 were deemed 
unable to participate due to illness or other reasons, and the remainders were 
contacted via mail by asking whether they would like to participate in the study. Of 
2,135 subjects, 1,100 were enrolled in the study and 1,099 attended the first clinic 
between March 2002 and September 2004 (response rate 57%) at the Menzies 
Institute for Medical Research, Australia. Follow-up data was collected for 875 
eligible participants (80%) at Phase 2 approximately 2.6 years later (range: 1.4–4.8 
years) and 769 eligible participants (70%) at Phase 3 approximately 5.1 years later 
(range: 3.6–6.9 years), respectively. The MRI machine was decommissioned halfway 
through the follow-up period; therefore, MRI scans were only available for 
approximately half of the follow-up participants at Phase 2 (n=425 of 875). MRI was 
not used for the measurement of structures at Phase 3. 
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Figure 3-1 Flow chart describing recruitment and withdrawal reasons for TASOAC 
participants. 
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3.2.3 Ethics 
The Southern Tasmanian Health and Medical Human Research Ethics Committee 
approved the Offspring and TASOAC study. And all participants provided written 
informed consent. 
3.3 Anthropometrics 
Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing 
removed) using a single pair of electronic scales (Seca Delta Model 707) calibrated 
using a known weight at the beginning of each clinic. Height was measured to the 
nearest 0.1 cm (with shoes and socks removed) using a stadiometer. BMI (kg/m2) was 
calculated.  
3.4 Magnetic Resonance Imaging  
MRI scans of the right knee in the Offspring and TASOAC study were acquired in the 
sagittal plane on a 1.5–T whole body magnetic resonance unit (Picker, Cleveland, 
OH) with use of a commercial transmit-receive extremity coil. The following image 
sequence was used: (1) a T1–weighted fat saturation three-dimensional gradient-
recalled acquisition in the steady state; flip angle 30˚; repetition time 31ms; echo time 
6.71 ms; field of view 16 cm; 60 partitions; 512 × 512–pixel matrix, slice thickness of 
1.5 mm without an interslice gap; (2) a T2-weighted fat saturation two-dimensional 
fast spin echo; flip angle 90°; repetition time 3,067 ms; echo time 112 ms; field of 
view 16 cm; 15 partitions; 228 × 256–pixel matrix, slice thickness of 4 mm with an 
inter-slice gap of 0.5–1.0 mm. 
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3.4.1 Knee cartilage volume 
Knee cartilage volume was determined by means of image processing on an 
independent work station using Osiris (University of Geneva) and measured by two 
trained and blinded observers as previously described [201]. The volumes of 
individual cartilage plates (medial tibia and lateral tibia) were isolated from the total 
volume by manually drawing disarticulation contours around the cartilage boundaries 
on a section by section basis. These data were then resampled by means of bilinear 
and cubic interpolation (area of 312 × 312 mm and 1.5 mm thickness, continuous 
sections) for the final three-dimensional rendering. The coefficient of variation (CV) 
for baseline and follow-up cartilage volume measures was 2.1% for medial tibial, and 
2.2% for lateral tibial cartilage [201]. Knee femoral cartilage volume was determined 
by means of image processing on an independent workstation using Cartiscope ™ 
(ArthroVision Inc., Montreal, QC, Canada), as previously described [202]. The 
segmentation of the cartilage-synovial interfaces was carried out with the semi-
automatic method under reader supervision and with corrections when needed. 
Cartilage volume was evaluated directly from a standardized view of three-
dimensional cartilage geometry as the sum of elementary volumes. The CV was 
approximately 1.6% for medial femoral and 2.9% for lateral femoral cartilage at 
baseline and follow-up [202]. The cartilage volume assessment was done for the 
medial and lateral condyles delineated by the Blumensaat’s line.  
3.4.2 Cartilage defects 
Cartilage defects were assessed on T1-weighted MR images at the medial tibial, 
medial femoral, lateral tibial, and lateral femoral sites, as previously described [203], 
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as follows: grade 0 = normal cartilage; grade 1 = focal blistering and 
intracartilaginous low-signal intensity area with an intact surface and base; grade 2 = 
irregularities on the surface or base and loss of thickness < 50%; grade 3 = deep 
ulceration with loss of thickness > 50%; and grade 4 = full-thickness chondral wear 
with exposure of subchondral bone. A cartilage defect also had to be present on at 
least two consecutive slices. The cartilage was considered to be normal if the band of 
intermediate signal intensity had a uniform thickness. The highest score was used if 
more than one defect was present on the same site. One observer scored the cartilage 
defects. Intraobserver repeatability was assessed in 50 subjects with an interval of at 
least one week between the two measurements. The intraclass correlation coefficients 
(ICCs) for the Offspring and TASOAC study were 0.93, 0.92, 0.95, and 0.80 at the 
medial tibia, medial femur, lateral tibia, and lateral femur, respectively. 
3.5 Radiographs 
A standing anteroposterior semiflexed view of the right knee with 15° of fixed knee 
flexion was performed. Radiographs were assessed using the Altman atlas [204]. Each 
of the following was assessed on a scale of 0–3: medial joint space narrowing (JSN), 
lateral JSN, medial femoral osteophytes, medial tibial osteophytes, lateral femoral 
osteophytes, and lateral tibial osteophytes. Each score was determined by consensus 
of two readers who simultaneously assessed the radiograph with immediate reference 
to the atlas. Intraobserver repeatability was assessed in 40 subjects with an interval of 
at least one week between the two measurements. ICCs ranged from 0.65–0.85. The 
presence of radiographic osteoarthritis (ROA) was defined as any score ≥1 for JSN or 
osteophytes. 
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3.6 Pain measurement 
3.6.1 Knee pain  
The WOMAC was utilized to assess knee pain. The subscales of the WOMAC which 
consists of five items (walking on flat surface, going up/down stairs, at night in the 
bed, sitting/lying and standing upright) with a 10-point scale ranging from 0 (no pain) 
to 9 (most severe pain) were used for this study [205]. Each item was summed to 
produce a total pain (0-45) score with higher scores indicating greater pain. A total of 
score of 1 or greater was considered as presence of knee pain.  
3.6.2 Multi-site pain 
The location of sites at which the participants experienced pain was measured by self-
reported questionnaire. Participants were asked whether they had pain (yes/no) in the 
following sites at present: neck, back, hands, shoulders, hips, knees or feet. The 
number of painful sites was summed to create a total number of painful site with a 
range from 0 to 7, which was then categorised into four groups (non-painful site, 1-2, 
3-4, 5-7 painful sites) according to the number of painful site groups with 
approximately equal numbers of participants reporting one or more painful sites 
[206]. Number of painful site types was also assessed on a regional basis, with total 
count of painful upper limb sites created by summing the number of painful upper 
limb sites (neck, hands and shoulders, range: 0–3), and count of painful lower limb 
sites created by summing number of hip, knees and feet (range: 0–3). 
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3.7 Summary of outcome factors, study factors, and covariates 
Table 3-1 summarises the variables used in each chapter of this thesis.   
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Table 3-1 Summary of outcome factors, study factors, and covariates used in this thesis 
Chapter 
Outcome 
factors 
Study factors Covariates 
4 Cartilage 
defects 
BMLs* 
Meniscal 
extrusion* 
Meniscal tear* 
Family history of 
knee OA 
Age, sex, BMI, knee injury*, smoking history*, ROA, baseline 
corresponding structure, and knee structures relevant to each other. 
5 Cartilage 
volume 
Cartilage 
defects 
Weight 
Family history of 
knee OA 
Age, sex, height, knee injury*, smoking history*, ROA, bone size* and 
cartilage defects†. 
6 Knee pain Family history of 
knee OA 
Age, sex, BMI, knee injury*, smoking history*, ROA, cartilage defects, 
BMLs*, meniscal pathology* and effusion*. 
7 MSP Fat mass* 
Fat mass index* 
BMI 
Age, sex, height‡, smoking history*, physical activity*, emotional 
problems*, education level* and employment*. 
8 Cartilage 
volume 
MSP Age, sex, BMI, physical activity*, pain medication*, baseline cartilage 
volume, cartilage defects and BMLs*. 
BMLs bone marrow lesions; OA osteoarthritis; BMI body mass index; ROA radiographic osteoarthritis; MSP multi-site pain 
*Measurement protocol described in “Materials and Methods” section of relevant chapter. 
†Cartilage defects were further adjusted in the analyses of cartilage volume. 
‡Height was only adjusted for fat mass. 
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3.8 Statistical analysis  
T-tests and Chi-square were used to compare differences in means and percentages 
where appropriate. P values less than 0.05 (two-tailed) were regarded as statistically 
significant throughout the thesis. The following chapters present the detailed 
descriptions of statistical analyses. Stata V.12.1 for windows (StataCorp, College 
Station, Texas, US) and SPSS Statistics (version 20, Chicago IL) were used to 
perform statistical analyses. 
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4.1 Introduction 
OA is the most common form of skeletal disorder worldwide and one of the leading 
causes of pain and disability, resulting in a large social and economic burden [14]. 
The knee joint is the major site of OA with a prevalence of 30% in those aged 65 and 
above [207].  
It is well-established that knee OA is a multifactorial and highly heterogeneous 
disease as a result of a complex interaction between local biomechanical factors, such 
as obesity, mechanical stress and muscle weakness, and systemic factors, such as age, 
sex and genetics [208]. Genetic factors have been extensively investigated in sibling 
studies, familial aggregation and twin pair studies, with heritability estimates of 
approximately 39-65% [127, 131, 209]. GWAS have identified multiple loci involved 
in the risk of knee OA, but there has been little independent replication [123, 134]; 
moreover, little is known about the contribution of genetic factors to progression of 
knee OA over time [41]. 
Previous studies have shown genetic contributions to knee structures and their 
changes, including bone size, cartilage volume, cartilage defects and muscle strength 
[210-213]. There are limited studies on BMLs [214], meniscal extrusion [215] and 
meniscal tears [216]. These studies have mainly been cross-sectional or short-term 
with no long-term studies. Therefore, the aim of this study was to describe whether 
offspring of people having at least one parent with TKR for severe knee OA had a 
higher rate of change in knee structures of relevance to osteoarthritis in comparison 
with controls with no knee OA family history over 8 to 10 years. 
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4.2 Materials and methods 
4.2.1 Participants 
This study was carried out in southern Tasmania in the capital city of Hobart. The 
initial measurements were taken from June 2000 to December 2001, and follow-up 
evaluations were conducted 2 years and 10 years later. Participants were selected 
from two sources, as described previously [207, 217]. Half of the participants were 
the adult children (offspring) of participants who had had a TKR performed for 
primary knee OA at any Hobart hospital from 1996-2000. This diagnosis was 
confirmed by reference to the medical records of the orthopaedic surgeon and the 
original radiograph where possible. The other half were controls selected at random 
from the state Electoral Roll (2000), without a history of knee OA in either parent 
which was confirmed by history and medical records (TJR). A total of 746 age- and 
sex-matched controls were identified. Among them, 125 participants who failed to 
meet the inclusion criteria were excluded, 216 refused to participate this study, 213 
were non-contactable or no response, and 192 met the inclusion criteria. Finally, 186 
individuals attended all clinical and questionnaires measurements at baseline. 
Participants from either group were excluded on the basis of contraindication to MRI 
(including metal sutures, presence of shrapnel, iron filing in eye, and claustrophobia). 
This study was approved by the Southern Tasmanian Health and Medical Human 
Research Ethics Committee and all participants provided informed written consent. 
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4.2.2 Anthropometrics 
Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing 
removed) using a single pair of electronic scales (Seca Delta Model 707) calibrated 
using a known weight at the beginning of each clinic. Height was measured to the 
nearest 0.1 cm (with shoes and socks removed) using a stadiometer. BMI (kg/m2) was 
calculated. 
4.2.3 Knee injury 
Knee injury was assessed at baseline by asking ‘Have you had a previous knee injury 
requiring non-weight-bearing treatment for more than 24 hours or surgery?’. 
4.2.4 Radiographs 
A standing anteroposterior semiflexed view of the right knee was performed in all 
participants and scored individually using the Altman atlas for osteophytes and JSN 
on a scale of 0-3 as previously described [218]. The presence of radiographic OA 
(ROA) was defined as any score ≥ 1 for JSN or osteophytes. 
4.2.5 Knee MRI 
An MRI scan of the right knee was performed with a 1.5T whole-body magnetic 
resonance unit (Picker, Cleveland, OH, US) using a commercial transmit-receive 
extremity coil. The following image sequences were used: (1) a T1-weighted fat 
suppression three-dimension gradient-recalled acquisition in the steady state, flip 
angle 55˚, repetition time 58 ms, echo time 12 ms, field of view 16 cm, 60 partitions, 
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512 × 512–pixel matrix, slice thickness of 1.5 mm without an interslice gap; (2) a T2-
weighted fat saturation two-dimensional fast spin echo, flip angle 90°, repetition time 
3,067 ms, echo time 112 ms, field of view 16 cm, 15 partitions, 228×256–pixel 
matrix, slice thickness of 4 mm with an inter-slice gap of 0.5–1.0 mm.  
4.2.5.1 Cartilage defects 
Cartilage defects at baseline and 10 years were assessed as previously described [219] 
on T1-weighted MR images at the medial tibial, medial femoral, lateral tibial, and 
lateral femoral sites, as follows: grade 0 = normal cartilage; grade 1 = focal blistering 
and intracartilaginous low-signal intensity area with an intact surface and base; grade 
2 = irregularities on the surface or base and loss of thickness < 50%; grade 3 = deep 
ulceration with loss of thickness > 50%; and grade 4 = full-thickness chondral wear 
with exposure of subchondral bone. The presence of any cartilage defect was defined 
as a score of ≥ 2 at any site. The average scores of cartilage defects at the medial 
tibiofemoral (0 to 8) and lateral tibiofemoral (0 to 8) compartments were used in the 
study. A cartilage defect score increase was defined as an increase of one or greater at 
any site. 
4.2.5.2 Meniscal extrusion 
The extent of meniscal extrusion on the medial or lateral edges of the tibial femoral 
joint space, not including the osteophytes, was evaluated at baseline and at 10 years 
for the anterior, body, and posterior horns of the menisci, as previously described [50, 
215]. A score from 0 to 2 was used (0 = no extrusion, 1 = partial meniscal extrusion, 
and 2 = complete meniscal extrusion with no contact with the joint space). The 
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presence of any meniscal extrusion was defined as any score ≥ 1. The scores of 
anterior, body and posterior horns of medial or lateral menisci were summed to create 
a total meniscal extrusion score for each of the medial and lateral tibiofemoral 
compartments which had a possible range from 0-6. A meniscal extrusion score 
increase was defined as an increase of one or greater at any site. 
4.2.5.3 Meniscal tears 
At baseline there were only T1-weighted MRI scans which were not suitable for 
comparison of meniscal tears and BMLs over time. Meniscal tears were assessed at 2 
years and 10 years for the anterior, body, and posterior horns of each of the medial 
and lateral menisci on 0-2 score (0 = no tear, 1 = simple tears of different types: 
longitudinal, oblique, radial or horizontal signifying loss < 50% area of meniscal 
tissue, and 2 = macerated tear signifying loss > 50% area of meniscal tissue), as 
previously described [50, 220]. The presence of any meniscal tear was defined as any 
score ≥ 1. The scores of anterior, body and posterior horns of medial or lateral 
menisci were summed to create a total meniscal tear score at the medial/lateral 
tibiofemoral compartment which had a possible range from 0-6. A meniscal tear score 
increase was defined as an increase of one or greater at any site. 
4.2.5.4 BMLs 
BMLs were assessed at 2 years and 10 years on T2-weighted MRI and defined as 
areas of increased signal adjacent to the subcortical bone at the medial tibial, medial 
femoral, lateral tibial and lateral femoral sites, as previously described [45]. The 
readers for BMLs were trained by a radiologist including the differentiation of OA-
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related BML from similar signal such as contusion/necrosis/edema etc. [221] and 
consulted the radiologist if there were any doubts. The maximum area (cm2) of the 
lesion of different sites was measured, and the BML with the largest size was 
recorded if more than one lesion was present at the same site. The presence of any 
BML was defined as any score > 0. The scores of BML at the medial tibiofemoral and 
lateral tibiofemoral compartments were the sum of the corresponding sites. To adjust 
for measurement error, a least significant criterion (LSC) [222] was used to define a 
significant change in BML size (based on previous studies [45, 223]). An increase in 
BML size was defined as any change greater than the LSC at any site. 
4.2.6 Data analysis 
T-tests and Chi-square tests were used to compare differences in means and 
percentage where appropriate. Logistic regression modelling was used to assess the 
potential relationships between the status of participants (offspring or controls) and 
four outcomes of knee structural change (increase in cartilage defect score, increase in 
meniscal extrusion score, increase in meniscal tear score, and increase in BML score), 
before and after adjustment for common confounders (Step1: age, sex, BMI, ROA, 
baseline variable of the outcome of interest, history of knee injury and smoking). To 
exclude a potential effect of other knee structural changes, further adjustment for knee 
structural changes of relevance to each other (Step 2) in this cohort was also 
conducted. P values less than 0.05 (2-tailed) or 95% confidence intervals (CIs) not 
including the “1” point were regarded as statistically significant difference. All 
statistical analyses were performed using SPSS Statistics (version 20, Chicago IL). 
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The Hochberg method was used to adjust for multiple testing on regression results 
[224]. 
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4.3 Results 
4.3.1 Participants 
A total of 372 participants (186 offspring and 186 controls) aged from 26-61years 
(mean age of 45 years) were enrolled at baseline. After 2 years (range 1.8-2.6 years), 
326 participants (162 offspring and 164 controls) took part and 219 participants (115 
offspring and 104 controls) were studied at 10 years (range 9.1-11.4 years). 
Comparison of the participants lost to follow-up with those included in the present 
study showed that the proportion of smokers in those lost to follow-up was higher 
(59% vs. 42%) but no significant differences in other study factors including 
structural abnormalities was observed (data not shown). 
Table 4-1 presents the characteristics of participants who completed 10 years of 
follow-up. There were no significant differences in terms of age, sex, height, history 
of knee injury and ROA at baseline between offspring and controls; however, 
offspring were heavier and had a higher proportion of smokers at baseline. 
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Table 4-1 Characteristics of participants* 
Parameter 
Offspring 
(n=115) 
Controls 
(n=104) 
P value 
Age, years  44.8 (6.8) 45.8 (6.5) 0.261 
Female (%)  60 55 0.435 
Height, cm  170.0 (8.5) 168.7 (8.9) 0.270 
Weight, kg  80.9 (17.2) 75.1 (14.6) 0.008 
BMI, kg/m2  27.9 (5.3) 26.3 (4.5) 0.018 
Previous knee injury (%)  15 23 0.116 
Ever smoking (%)  50 33 0.008 
Radiographic OA (%)  17 18 0.865 
Total cartilage defect score 4.2 (1.2) 3.9 (1.3) 0.095 
Any cartilage defect (%)a   41 32 0.197 
Total meniscal extrusion score 0.2 (0.6) 0.1 (0.3) 0.096 
Any meniscal extrusion (%)b 10 7 0.423 
Total  meniscal tear score 0.5 (1.3) 0.3 (0.8) 0.313 
Any meniscal tear (%)b 21 23 0.744 
Total BML score, cm2 0.3 (0.7) 0.2 (0.5) 0.119 
Any BML (%)c 55 51 0.529 
Bold denotes statistically significant result; BMI, body mass index; OA, osteoarthritis; BML bone 
marrow lesion; 
*Mean (SD) except for percentages; P values determined by t-test or Pearson Chi-square test (where 
appropriate);  
aDefined as score ≥ 2 in any compartment; 
bDefined as score ≥ 1 in any compartment; 
cDefined as score > 0 in any compartment. 
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4.3.2 Offspring-control status and knee structural changes 
4.3.2.1 Cartilage defects 
In this sample, no significant differences were found between offspring and controls 
in the prevalence of knee cartilage defect as well as the mean tibiofemoral cartilage 
defect score at baseline (Table 4-1). However, there was a significant difference in the 
change in cartilage defect score in the medial but not the lateral tibiofemoral 
compartment (Table 4-2). 
In multivariable analysis after adjustment for common confounders, the odds ratio 
(OR) for medial tibiofemoral cartilage defect increase in the offspring group was 2.5-
fold higher than in controls (Table 4-3). This association persisted after further 
adjustment for other structural factors. 
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Table 4-2 Differences in knee structural changes between offspring and controls* 
Parameter 
Offspring 
(n=115) 
Controls 
(n=104) 
P value 
Change in cartilage defects†    
Medial compartment 1.0 (1.5) 0.5 (1.2) 0.007 
Lateral compartment 0.5 (1.1) 0.5 (1.0) 0.848 
Change in meniscal extrusion†    
Medial compartment 0.3 (0.8) 0.1 (0.4) 0.027 
Lateral compartment 0.0 (0.0) 0.1 (0.4) 0.181 
Change in meniscal tear§    
Medial compartment 0.4 (1.0) 0.1 (0.5) 0.012 
Lateral compartment 0.1 (0.7) 0.1 (0.4) 0.778 
Change in BML§, cm2    
Medial compartment 0.2 (0.7) 0.1 (0.5) 0.298 
Lateral compartment 0.3 (0.7) 0.1 (0.4) 0.113 
Bold denotes statistically significant result; BML bone marrow lesion; 
*Change in mean score (SD); 
†Change in the knee structure over 10 years; 
§Change in the knee structure over 8 years. 
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Table 4-3 Association between offspring-controls status and any increase in 
structural abnormality 
Outcome 
Multivariable analysis‡  Multivariable analysis‡‡   
OR (95% CI) P value  OR (95% CI) P value 
Cartilage defects†      
Medial compartment 2.47 (1.28, 4.77)* 0.007  3.04 (1.32, 7.02)* 0.009 
Lateral compartment 1.17 (0.59, 2.30) 0.659  1.20 (0.52, 2.75) 0.672 
Meniscal extrusion†      
Medial compartment 3.12 (1.07, 9.11) 0.038  10.11 (1.91, 53.48)* 0.007 
Lateral compartment NA NA  NA NA 
Meniscal tear§      
Medial compartment 3.81 (1.24, 11.73)* 0.020  5.34 (1.42, 20.15)* 0.013 
Lateral compartment NA NA  NA NA 
BMLs§      
Medial compartment 1.56 (0.77, 3.16) 0.218  0.94 (0.40, 2.22) 0.890 
Lateral compartment 1.49 (0.77, 2.90) 0.239  1.33 (0.61, 2.92) 0.476 
Bold denotes statistically significant result; OR odd ratio; CI confidence interval; NA not applicable; 
BMLs bone marrow lesions; 
‡Adjusted for age, sex, body mass index, knee injury, smoking history, radiographic osteoarthritis, 
baseline corresponding structure; 
‡‡Further adjusted for all other structural changes in table. 
†Change in the knee structure over 10 years; 
§Change in the knee structure over 8 years. 
*Denotes significant association that passes Hochberg adjustment for multiple testing. 
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4.3.2.2 Meniscal extrusion 
There were no differences in the meniscal extrusion score between the two groups at 
baseline (Table 4-1), but offspring had a greater increase in average score in the 
medial but not lateral tibiofemoral compartment (Table 4-2). 
In multivariable analysis, offspring had a 3.1-fold higher risk of meniscal extrusion 
score increase in the medial tibiofemoral compartment and this increased after 
adjustment for other structures (Table 4-3). This analysis cannot be performed for 
lateral meniscal extrusion score increase due to the small numbers of cases.  
4.3.2.3 Meniscal tear 
At 2 years, meniscal tears did not differ between offspring and controls (Table 4-1). 
Offspring had a greater increase in the score in the medial tibiofemoral compartment 
over 8 years (Table 4-2). 
In multivariable analysis OR for offspring having a meniscal tear score increase as 
controls was 3.8-fold higher for the medial tibiofemoral compartment. Consistent 
results were observed after further adjustment for changes in other structures (Table 
4-3). Meaningful ORs cannot be obtained for the lateral tibiofemoral compartment as 
only two participants had increased scores. 
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4.3.2.4 BML 
There were no differences between offspring and controls in terms of the prevalence 
of BML, BML score at the 2-year visit, and change in BML size in any compartment 
over 8 years (Table 4-1 and Table 4-2).  
After adjustment for multiple testing using the Hochberg method (Table 4-3), the 
significant associations remained apart from the meniscal extrusion before adjustment 
for all other structural changes suggesting these results are not due to chance. 
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4.4 Discussion 
To the best of our knowledge, this is the first longitudinal study with a long-term 
follow-up to examine the relationship between family history of knee OA and knee 
structural change. We found offspring who had at least one parent with TKR for 
severe knee OA had an increased   risk of worsening of knee structural abnormalities 
including cartilage defects, meniscal extrusion and tears but not BMLs, suggesting 
familial factors may be involved in specific knee structural damage. These 
associations were specific for the medial but not the lateral tibiofemoral compartment, 
most likely reflecting a predisposition to medial knee OA in their parents. 
Furthermore, these findings may suggest a greater environmental effect on change in 
BMLs and change in lateral cartilage defect, and thus they could be modifiable. 
Based on familial aggregation and twin studies, there is substantial evidence that 
genetic factors have an important role in the aetiology of knee OA [127, 131, 209]. 
Most studies are cross-sectional or case-control studies. There are few studies 
describing the role of genetic factors in structural knee OA progression. Botha-
Scheepers et al. [225] reported siblings of proband having progression had 4.3-fold 
greater risk of radiologic progression of JSN in the knee over 2-year follow-up. Zhai 
et al. [226] also found a strong genetic influence on the progression of ROA in a 
longitudinal twin study. To date, limited data are available on the roles of genetic 
factors in the pathogenesis of progression in knee structures prior to end-stage disease 
[211, 213, 219]. It is known that cartilage defects, BMLs and meniscal pathology play 
an important role in knee OA, being associated with the adverse structural outcomes 
[26, 45, 49, 227] and knee pain [228]. Previously, in a larger sample from this cohort, 
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we reported that offspring with family history of knee OA had a higher prevalence of 
cartilage defects [212] as compared to controls but no differences in the prevalence of 
meniscal extrusion [215] and tears [216]. However, in the subsample of participants 
with available longitudinal data, there was no statistical difference in cartilage defects 
at baseline most likely due to the smaller sample size. Nonetheless, despite the 
smaller sample size available for long-term follow-up, we showed that offspring had a 
greater increase in multiple structural abnormalities, independent of baseline 
structures. The only exception was no effect for BMLs but the ORs were around one, 
suggesting that this is not a power issue. 
Offspring had an elevated risk for an increase in cartilage defects, meniscal extrusion 
and tears over 8 to 10 years in the medial tibiofemoral compartment after adjustment 
for age, sex, BMI, ROA, knee injury, smoking and other knee structural factors of 
relevance to each other, suggesting familial effects on progression in these structures 
and the influence of familial factors is compartment-specific. These results are 
comparable with an earlier familial study that reported a 3.2-fold increased risk of 
prevalence of ROA in siblings [229], but appear to be greater than those reported by 
Neame et al. [230]. The difference in results may be explained by the difference in 
study population of the study by Neame et al. where siblings were compared with the 
subjects from knee pain studies. This could overestimate the prevalence of knee OA 
among this group, and therefore resulting in a lower risk of prevalence of knee OA in 
siblings than ours. Additionally, a previous study with 2-years follow-up in this 
population found that offspring had a greater increase in the medial cartilage defects 
[219]. However, it is unknown which genes underlie the progression of cartilage 
defects.  
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Although meniscal pathology may be the result of knee injury, knee malalignment 
and high BMI [227], there are data supporting a genetic contribution to meniscal 
pathology [216, 231, 232]. Sun et al. [231] reported significantly higher levels of 
gene expression responsible for biological processes in OA meniscal cells as 
compared to normal meniscal cells, which suggests that aberrant expression of genes 
may be involved in meniscal pathology. Furthermore, in a longitudinal study by 
Englund et al., people with bony enlargement of finger joints had an increased risk of 
the development of meniscal pathology, implying that meniscal pathology may be 
affected by genetic factors, given a strong genetic component of bony enlargement of 
finger joints [232]. A previous cross-sectional study from our group found that 
offspring with a family history of knee OA had a two-fold higher risk for the presence 
of lateral anterior and posterior meniscal tear as compared to controls, indicated 
genetic factors may be a risk factor for meniscal tears [216]. The present study 
supports independent familial effects on each knee structural change as the higher risk 
of progression in cartilage defects, meniscal extrusion and tears in offspring was 
observed after adjustment for known confounders and for each other. All of these 
factors have been considered part of the MRI diagnosis of knee OA [233] and thus 
could be identified early in ‘at risk’ people. 
The present study failed to detect any differences in the progression of BMLs in any 
compartment between offspring and controls, which contrasts with a previous sib pair 
study in this sample that showed a heritability estimate of 50% for prevalent BMLs 
[214].Thus, it may be that familial factors are only responsible for the initial 
development of BMLs but not for progression.  
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Despite some strengths of this study, including its longitudinal design, long-term 
follow-up, and the use of MRI to evaluate knee structural changes, there are several 
potential limitations. Firstly, although some potential confounders have been adjusted 
in the current study, we cannot rule out the possibility that unidentified confounders 
or unmeasured factors influence the risk for change in knee structures independently 
of family history of knee OA. For instance, although results of the association 
between smoking and knee OA have been inconsistent from previous studies and a 
recent meta-analysis including 38 studies also failed to demonstrate a causal 
relationship between them [234], there was a high proportion of smokers in those lost 
to follow-up and offspring at baseline, this may suggest more psychosocial problems 
in those people. Furthermore, although knee alignment was not assessed in the present 
study, a previous study [235] from this cohort demonstrated that this factor is not 
related to knee structural change, suggesting the absence of alignment assessment is 
not a limitation for this study. Secondly, because of the rarity of lateral meniscal tears 
and extrusion, we were unable to determine if familial factors have effects on 
progression in lateral compartment. Thirdly, genetic factors may play different roles 
across different ethnic groups [236]. The present study only recruited Caucasians, 
thus it is inappropriate to extrapolate to other ethnic groups. Lastly, the loss to follow-
up may lead to bias; however, there were no significant differences between the 
participants included in this study and the rest of the cohort in many studied factors 
apart from only a slightly higher percentage of smokers in those lost to follow-up and 
adjusting for this factor did not influence results. 
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In conclusion, offspring with family history of knee OA have an increased risk of 
progression of multiple knee structures in the medial tibiofemoral compartment 
compared to controls suggesting pleiotropic familial effects. 
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Chapter 5: The interaction between weight and family 
history of total knee replacement with knee cartilage: a 10-
year prospective study  
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5.1 Introduction  
Knee OA is the most common form of arthritis worldwide and affects an estimated 
30% of individuals aged over 65 years, often leading to pain, disability and reduced 
quality of life [15, 237]. Despite this, its etiology remains poorly understood.  
Knee OA is considered to be a multifactorial and heterogeneous disease affected by 
genetic and multiple environmental factors [123, 238]. Previous family-based studies 
have shown a strong genetic basis for OA, with the estimated heritability of 
approximately 39-65% [239, 240]. There are 11 loci associated with OA now 
identified in GWAS, although the effect sizes are small [15]. Being overweight or 
obese is one of the strongest environmental risk factors for the development and 
progression of radiographic knee OA [2, 148]. A recent meta-analysis has shown an 
over two-fold increased risk of radiographic knee OA in those who are overweight or 
obese [148]. An earlier study has reported that the effect of variation in the FTO gene 
on increased risk of OA is mediated solely through its effect on BMI [241]. 
Cartilage volume and defects, measured by MRI, are examples of the early structural 
changes of pre-radiographic knee OA. Both predict clinically relevant endpoints such 
as knee replacement [27, 28, 242]. Most studies investigating the effect of 
weight/BMI on knee cartilage have mainly been cross-sectional or short-term follow-
up studies and have reported generally consistent detrimental relationships of 
increasing weight with cartilage defects but not cartilage volume [150]. Given that 
overweight/obesity is a strong risk factor for knee OA, and genetic factors are 
implicated in the pathogenesis of knee OA, it is important to understand how genetic 
factors interact with weight to influence the risk of pre-radiographic knee OA. The 
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aim of this longitudinal study was, therefore, to examine the effects of weight on knee 
cartilage volume and defects over 10 years in offspring having at least one parent with 
a TKR for severe primary knee OA, and in controls with no family history of knee 
OA. 
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5.2 Methods 
5.2.1 Participants 
This study was carried out in Hobart, Tasmania. Baseline measurements were taken 
from June 2000 to December 2001, and follow-up evaluations were conducted after 
approximately 2 and 10 years. Participants were selected from two sources, as 
described previously [207, 217]. Half of the participants were the adult children 
(offspring) of people who had a TKR performed for primary knee OA (defined as OA 
lacking known cause) at any Hobart hospital from 1996-2000. This diagnosis was 
confirmed by reference to the medical records of the orthopaedic surgeon and the 
original radiograph where possible. The other half were controls selected at random 
from the state Electoral Roll (2000), without a history of knee OA in either parent 
which was confirmed by history and medical records. Participants from either group 
were excluded on the basis of contraindication to MRI (including metal sutures, 
presence of shrapnel, iron filing in eye, and claustrophobia). The study was approved 
by the Southern Tasmanian Health and Medical Human Research Ethics Committee 
and all participants provided informed written consent. 
5.2.2 Anthropometrics 
Anthropometrics were measured at baseline, 2 and 10 years. Weight was measured to 
the nearest 0.1 kg (with shoes, socks and bulky clothing removed) using a single pair 
of electronic scales (Seca Delta Model 707) calibrated at the beginning of each clinic. 
Height was measured to the nearest 0.1 cm (with shoes and socks removed) using a 
stadiometer. BMI (kg/m2) was calculated. 
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5.2.3 History of knee injury and smoking 
Knee injury was assessed at baseline by asking ‘Have you had a previous knee injury 
requiring non-weight-bearing treatment for more than 24 hours or surgery?’. Smoking 
history was assessed at baseline by asking ‘Have you ever smoked at least seven 
cigarettes, cigar or pipes every week for at least three months?’. 
5.2.4 Radiographs 
A standing anteroposterior semiflexed view of the right knee was performed at 
baseline and scored using the Altman atlas for osteophytes and JSN on a scale of 0-3 
as previously described [218]. The presence of ROA was defined as any score ≥ 1 for 
JSN or osteophytes. 
5.2.5 Knee MRI 
An MRI scan of the right knee was performed with a 1.5T whole-body magnetic 
resonance unit (Picker, Cleveland, OH, US) using a commercial transmit-receive 
extremity coil at baseline, 2-year and 10-year follow-up. The following image 
sequences were used: a T1-weighted fat suppression three-dimension gradient-
recalled acquisition in the steady state, flip angle 55˚, repetition time 58 ms, echo time 
12 ms, field of view 16 cm, 60 partitions, 512 × 512–pixel matrix, slice thickness of 
1.5 mm without an interslice gap. 
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5.2.5.1 Cartilage volume  
Knee cartilage volume was determined by means of image processing on an 
independent work station using Osiris (University of Geneva) as previously described 
[243, 244]. The volumes of individual cartilage plates (medial tibia and lateral tibia) 
were isolated from the total volume by manually drawing disarticulation contours 
around the cartilage boundaries on a section by section basis. These data were then 
resampled by means of bilinear and cubic interpolation (area of 312 × 312 mm and 
1.5 mm thickness, continuous sections) for the final three-dimensional rendering. The 
CV for cartilage volume measures was 2.1% for medial tibial, and 2.2% for lateral 
tibial cartilage [243]. Knee femoral cartilage volume was determined by means of 
image processing on an independent workstation using Cartiscope ™ (ArthroVision 
Inc., Montreal, QC, Canada), as previously described [50, 245, 246]. The 
segmentation of the cartilage-synovial interfaces was carried out with the semi-
automatic method under reader supervision and with corrections when needed. 
Cartilage volume was evaluated directly from a standardized view of three-
dimensional cartilage geometry as the sum of elementary volumes. The CV was 
approximately 2.0% [245]. The cartilage volume assessment was done for the medial 
and lateral condyles delineated by the Blumensaat’s line [246]. The medial and lateral 
tibiofemoral cartilage volume created for this study were the sum of the cartilage 
volume of the corresponding sites. 
5.2.5.2 Cartilage defects 
Cartilage defects were assessed as previously described [219] on T1-weighted MRI at 
the medial tibial, medial femoral, lateral tibial, and lateral femoral sites, as follows: 
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grade 0 = normal cartilage; grade 1 = focal blistering and intracartilaginous low-
signal intensity area with an intact surface and base; grade 2 = irregularities on the 
surface or base and loss of thickness <50%; grade 3 = deep ulceration with loss of 
thickness >50%; and grade 4 = full-thickness chondral wear with exposure of 
subchondral bone. The ICCs ranged from 0.89–0.90 for intra-observer repeatability. 
Interobserver reliability was assessed in 50 MR images and yielded an ICC of 0.85–
0.90 [247]. The presence of any cartilage defect at medial or lateral tibiofemoral 
compartment was defined as a score of ≥2 at either tibial or femoral site. 
5.2.5.3 Bone area 
The tibial plateau bone area were determined, as described previously [248]. Medial 
and lateral tibial plateau area was determined by creating an isotropic volume from 
the three input images closest to the joint after reformatting in the axial plane. The 
areas of the medial and lateral tibial plateaus were then directly measured from these 
images. The CV was 2.3% and 2.4% for the medial and lateral tibial plateau [248]. 
5.2.6 Data analysis 
The continuous and categorical variables were respectively presented as Mean ± 
standard deviation (SD) and percentages. T-test and Chi-square tests were used to 
compare the differences in means and percentages where appropriate. Ordinal χ2 test 
(Kruskal-Wallis test) was used to test if there was a trend of prevalence of cartilage 
defects across category of body mass index. Longitudinal data were analysed using 
mixed-effects models that take the dependence of repeated observations within 
participants into account and use all data, thus the participants who were lost to 
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follow-up also were included in the analyses. Linear and poisson mixed-effects model 
with random intercept for participants were used to assess the potential associations of 
weight with  cartilage volume and defects, respectively, before and after adjustment 
for age, sex, height, smoking history, knee injury, corresponding bone size and ROA 
where appropriate. Interaction between weight and offspring-control status was tested 
using full longitudinal dataset in the model and was found significant (P≤0.2 is 
considered as statistical significance [249]), suggesting that the effect of weight on 
cartilage volume/defects was different in offspring and control groups. We, therefore 
did subgroup analyses in offspring and control group separately. Furthermore, we also 
performed separate mixed-effect models with random intercept for participants and 
‘weight × time’ interaction term to determine their temporal associations. Body 
weight was standardised by dividing by SD; therefore, all beta or relative risk (RR) 
represented cartilage volume or defects associated with per SD increase of body 
weight. We also estimated how much the genetic ‘load’ contributes to the risk of 
cartilage defects due to overweight/obesity through calculating the R square change in 
the model before and after adjustment for offspring-control status. Inverse probability 
weighting was used to determine whether loss to follow-up biased our results. All 
statistical analyses were performed using Stata V.12.1 for windows (StataCorp, 
College Station, Texas, US). P≤0.05 (two-tailed) was regarded as statistically 
significant. 
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5.3 Results 
The characteristics of participants at each time-point are presented in Table 5-1. A 
total of 372 participants with 186 offspring and 186 controls aged 26–61 years (mean 
age of 45 years) participated in this study at baseline. 326 and 219 participants 
underwent follow-up assessment at 2 and 10 years, respectively. No significant 
differences between participants followed (n=219) and those lost to follow-up 
(n=153) in all baseline studied factors apart from a higher proportion of smoking 
history in loss to follow-up group (59% vs. 42%). There were increases in mean 
weight/BMI over 10 years. Medial and lateral tibiofemoral cartilage volume 
decreased and the prevalence of cartilage defects increased from baseline to 10 years. 
At baseline, there were no signiﬁcant differences between offspring and controls in 
demographics, ROA, bone size, cartilage volume, defects (scores and prevalence); 
however, offspring weighted more and had a higher BMI compared with controls. 
There was increase in weight over 10 years in both group (Table 5-2). 
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Table 5-1 Characteristics of participants at each time-point* 
Characteristics 
Baseline 
(n=372) 
Phase 2 
(n=326) 
Phase 3 
(n=219) 
Follow-up, years 0 2.3±0.4 10.2±0.5 
Age, years 45.2±6.9 47.5±8.6 55.4±6.6 
Female (%) 58 58 58 
Height (cm) 169.1±8.5 168.6±8.6 168.6±8.8 
Weight (kg) 77.5±15.5 78.7±16.2 80.1±17.0 
Body mass index (kg/m2) 27.1±4.7 27.6±5.0 28.1±5.3 
Ever smoked (%)† 49   
Previous knee injury (%)† 20   
Radiographic osteoarthritis (%)† 21   
Medial bone area (cm2)† 17.4±2.7   
Lateral bone area (cm2)† 12.0±2.0   
Knee cartilage volume (ml)    
Medial tibiofemoral 6.8±1.7 6.3±1.6 5.5±1.5 
Lateral tibiofemoral 7.4±1.9 6.9±1.8 6.3±1.7 
Knee cartilage defect prevalence(%)‡    
Medial tibiofemoral 25 29 46 
Lateral tibiofemoral 17 22 30 
*Values are the Mean±SD except for percentages;  
†Variables were measured at baseline. 
‡Defined as defect score≥2 in tibial or femoral compartment. 
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Table 5-2 Characteristics of participants* 
Characteristics 
Controls 
(n=184) 
Offspring 
(n=183) 
P value 
Age, years 45.3±6.9 45.1±6.9 0.849 
Female (%) 58 57 0.798 
Height (cm) 169.0±8.7 169.1±8.3 0.917 
Weight (kg) 75.6±14.9 79.5±15.8 0.018 
Body mass index (kg/m2) 26.4±4.4 27.7±4.9 0.007 
Ever smoked (%) 44 53 0.085 
Previous knee injury (%) 22 17 0.198 
Radiographic osteoarthritis (%) 17 25 0.138 
Medial bone area (cm2) 17.2±2.8 17.7±2.6 0.089 
Lateral bone area (cm2) 11.9±2.1 12.0±2.0 0.608 
Knee cartilage volume (ml)    
Medial tibiofemoral 6.7±1.8 6.9±1.5 0.273 
Lateral tibiofemoral 7.2±1.9 7.6±1.9 0.106 
Knee cartilage defect score (0–8)    
Medial tibiofemoral 2.0±0.8 2.2±0.8 0.129 
Lateral tibiofemoral 1.9±0.7 2.0±0.8 0.245 
Knee cartilage defect prevalence (%)†    
Medial tibiofemoral 21 29 0.153 
Lateral tibiofemoral 17 17 0.907 
Change in weight (kg) 2.1±6.0 1.9±8.9 0.865 
*Values are the Mean±SD except for percentages;  
†Defined as defect score≥2 in tibial or femoral compartment. 
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Table 5-3 describes the baseline characteristics of participants by median weight in 
offspring and controls. 367 participants (184 controls and 183 offspring) with 
complete data were included for the analyses. There were no differences between 
participants below and above or equal median weight in terms of age, smoking history 
and prevalence of ROA in either controls or offspring. In both offspring and controls, 
participants above or equal median weight were more likely to be men, taller, have a 
higher rate of knee injury and greater bone size and cartilage volume. Cartilage defect 
score (but not prevalence) was greater in participants above or equal median weight 
than participants below median weight in offspring; however, these were not different 
in controls. The prevalence of medial tibiofemoral cartilage defects increased with 
each category of BMI in offspring at each phase but became less over time (P for 
trend<0.05 at baseline and Phase 2 and P=0.126 for Phase 3), and overweight/obese 
offspring had a higher prevalence of medial tibiofemoral cartilage defects than 
overweight/obese controls (Figure 5-1). Furthermore, compared with those with 
weight loss, participants with weight stable and weight gain had a higher proportion 
with an increase in medial tibiofemoral cartilage defects (Figure 5-2). 
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Table 5-3 Characteristics of participants at baseline* 
Characteristics 
Controls 
(n=184) 
 
Offspring 
(n=183) 
Weight < median 
(n=95) 
Weight ≥ median 
(n=89) 
P value  
Weight < median 
(n=86) 
Weight ≥ median 
(n=97) 
P value 
Age, years 44.8±7.0 45.8±6.9 0.300  44.4±7.4 45.7±6.3 0.208 
Females (%) 81 34 <0.001  79 37 <0.001 
Height (cm) 164.9±6.8 173.5±8.3 <0.001  165.2±5.7 172.6±8.7 <0.001 
Ever smoked (%) 41 47 0.402  56 51 0.474 
Previous knee injury (%) 17 28 0.067  10 23 0.028 
Radiographic knee OA (%) 14 20 0.362  20 30 0.228 
Medial bone area (cm2) 15.9±2.2 18.6±2.7 <0.001  16.2±1.8 19.1±2.5 <0.001 
Lateral bone area (cm2) 11.0±1.6 13.0±2.0 <0.001  11.1±1.4 12.9±2.1 <0.001 
Knee cartilage volume (ml)        
Medial tibiofemoral 6.0±1.4 7.5±1.9 <0.001  6.2±1.2 7.6±1.5 <0.001 
Lateral tibiofemoral 6.3±1.5 8.1±1.9 <0.001  6.6±1.3 8.5±1.9 <0.001 
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Knee cartilage defect score (0–8)        
Medial tibiofemoral 1.9±0.9 2.2±0.7 0.056  2.0±0.7 2.4±0.8 0.010 
Lateral tibiofemoral 1.8±0.7 1.8±0.7 0.753  1.8±0.7 2.1±0.8 0.033 
Knee cartilage defect prevalence (%)†        
Medial tibiofemoral 17 25 0.299  20 37 0.055 
Lateral tibiofemoral 17 17 1.000  14 20 0.407 
Bold denotes statistically significant results in either offspring or control group determined by t test or Pearson χ2 test (where appropriate). BMI, bone mass index; OA, 
osteoarthritis;  
*Values are the Mean±SD except for percentages;  
†Defined as defect score≥2 in tibial or femoral compartment. 
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Figure 5-1 Concurrent associations between category of body mass index and prevalence of medial tibiofemoral cartilage defects at each phase 
in (A) offspring; (B) controls. The bars represent prevalence of medial tibiofemoral cartilage defects in normal, overweight and obese group 
(Normal: body mass index<25; Overweight: 25≤body mass index<30; Obesity: body mass index≥30). P for trend determined by Kruskal-Wallis 
test. 
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Figure 5-2 Increase in medial tibiofemoral cartilage defects among those with weight 
loss, weight stable and weight gain over 10 years. An increase in medial tibiofemoral 
cartilage defect was defined as an increase of 1 or greater. Weight loss, weight stable 
and weight gain were defined as those who lost relative weight change of 5% or 
greater, those who gained or lost less 5% and those who gained 5%. P for trend 
determined by Kruskal-Wallis test. 
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Table 5-4 shows the association between weight and knee tibiofemoral cartilage 
volume in offspring and controls over 10 years, based on mixed-effects linear 
regression. In multivariable analyses with adjustment for age, sex and height; weight 
is negatively associated with medial but not lateral tibiofemoral cartilage volume 
which approached but did not reach statistical significance (P=0.061) in the offspring. 
This association persisted after further adjusting for smoking history, previous knee 
injury, ROA, bone size and cartilage defects. There was a significant weight × time 
interaction with lateral tibiofemoral cartilage volume over 10 years (interaction: β=-
0.02 ml, P<0.001), as shown in Figure 5-3. This result demonstrates that the 
association between weight and lateral cartilage volume became more negative as 
time increased; namely, the decrease in lateral tibiofemoral cartilage volume per SD 
increase in weight was 0.02 ml greater every year. In contrast, there were no 
significant associations of weight with cartilage volume loss at any compartments in 
controls. 
Chapter 5 – Interaction between family history of knee osteoarthritis and weight with 
knee cartilage 
88 
 
Table 5-4 Association between weight and knee tibiofemoral cartilage volume 
over 10 years  
 Increase in weight  per SD* 
 Model 1†   Model 2‡  
 β 95% CI  β 95% CI 
Offspring      
Medial tibiofemoral -0.21 -0.38, -0.04  -0.28 -0.49, -0.07 
Lateral tibiofemoral§ -0.17 -0.35, 0.01  -0.19 -0.38, 0.01 
Controls      
Medial tibiofemoral -0.12 -0.33, 0.09  -0.21 -0.47, 0.04 
Lateral tibiofemoral -0.07 -0.26, 0.12  -0.11 -0.33, 0.10 
Bold denotes statistically significant result. β beta coefficient; CI confidence interval;  
*β (95%CI): regression coefficient (95% confidence interval) estimated by mixed-effects linear 
regression representing the change in mean cartilage volume associated with a per SD change in 
weight; 
†Adjusted for age, sex and height; 
‡Further adjusted for ever smoking, previous knee injury, radiographic knee osteoarthritis, 
corresponding bone size and cartilage defects. 
§There is an interaction between weight and time. 
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Figure 5-3 Interaction between weight and time on lateral knee cartilage volume in 
offspring. There was a significant interaction between weight and time on lateral knee 
cartilage volume. The effect of increasing weight on lateral knee cartilage volume 
becomes more negative over time. The model adjusted for common covariates 
including age, sex, height, smoking, knee injury, radiographic knee osteoarthritis, 
bone size and cartilage defects. 
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Table 5-5 shows the association between weight and cartilage defects in offspring and 
controls over time, based on mixed-effects poisson regression. After adjustment for 
age, sex and height, the odds of medial and lateral cartilage defects increased with 
increasing weight at all time-points for offspring. These associations remained 
significant after further adjustment for other potential confounders. Furthermore, 
there was a significant weight × time interaction for medial cartilage defects, 
indicating the association between weight and medial cartilage defects decreased over 
time. Similarly, we did not observe significant associations between weight and 
cartilage defects in controls. After using inverse probability weighting, our results 
were very similar. 
Genetic ‘load’ contributing to the risk of medial tibiofemoral cartilage defects due to 
overweight/obesity was also estimated. Before and after adjustment for offspring-
control status, R2 increased from 0.56 to 0.66 (approximately 18% increase, P=0.011), 
suggesting that genetic ‘load’ accounts for 18% of risk of cartilage defects due to 
overweight/obesity.  
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Table 5-5 Association between weight and knee tibiofemoral cartilage defects 
over 10 years* 
 Increase in weight  per SD  
 Model 1†   Model 2‡  
 RR 95% CI  RR 95% CI 
Offspring      
Medial tibiofemoral§ 1.32 1.14, 1.54  1.27 1.07, 1.51 
Lateral tibiofemoral 1.28 1.05, 1.57  1.24 1.00, 1.54 
Controls      
Medial tibiofemoral 1.06 0.81, 1.39  1.05 0.79, 1.38 
Lateral tibiofemoral 0.77 0.52, 1.14  0.74 0.50, 1.11 
Bold denotes statistically significant result. RR relative risk; CI confidence interval;  
*RR (95%CI): relative risk (95% confidence interval) estimated by mixed-effects poisson regression; 
†Adjusted for age, sex and height;  
‡Further adjusted for ever smoking, previous knee injury and radiographic knee osteoarthritis; 
§There is an interaction between weight and time. 
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Appendices 5-1 Association between weight and knee tibiofemoral cartilage 
volume/defects over 10 years in the whole population* 
 Increase in weight  per SD  
 Model 1†   Model 2‡  
Cartilage volume β 95% CI  β 95% CI 
Medial tibiofemoral -0.17 -0.30, -0.04  -0.28 -0.45, -0.12 
Lateral tibiofemoral§ -0.12 -0.25, 0.01  -0.16 -0.30, -0.01 
Cartilage defects RR 95% CI  RR 95% CI 
Medial tibiofemoral§ 1.27 1.12, 1.45  1.21 1.05, 1.39 
Lateral tibiofemoral 1.13 0.94, 1.36  1.05 0.87, 1.29 
Bold denotes statistically significant result. RR relative risk; CI confidence interval;  
*RR (95%CI): relative risk (95% confidence interval) estimated by mixed-effects poisson regression; 
†Adjusted for age, sex and height;  
‡Further adjusted for ever smoking, previous knee injury and radiographic knee osteoarthritis. For 
cartilage volume, cartilage defects were additionally adjusted; 
§There is an interaction between weight and time. 
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5.4 Discussion 
This study found that detrimental associations between weight and knee cartilage over 
10 years in this mid-life population were consistently stronger in the offspring of 
people with TKR for severe primary knee OA, as compared to controls with no 
family history of knee OA. This suggests possible genetics-environment interaction 
with regard to overweight/obesity in the pathogenesis of early-onset knee OA. 
Although overweight/obesity is a well-established risk factor for the development of 
radiographic knee OA [2, 148], the results from previous studies on knee cartilage on 
MRI are mixed [150]. The current study found medial cartilage volume to be 
detrimentally associated with weight in the whole population (Appendices 5-1). 
Although this contrasts to some previous findings, with our initial reports from this 
cohort [250] and similar studies [152, 251-257], showing no effects of weight/BMI on 
cartilage volume either in cross-sectional or longitudinal studies, our results are 
consistent with some studies. For instance, an earlier cross-sectional study in an older 
population from our group found a significant negative association of BMI with 
cartilage volume [159]. A previous study with 1-year follow-up showed that weight 
loss in obese individuals was associated with reduced medial femoral cartilage 
thickness loss [258]. Furthermore, Teichtahl et al. [259] reported that weight loss was 
associated with reduced medial tibial cartilage loss in a 2.3-year follow-up study. 
Similarly, in a 4-year follow-up study by Bucknor et al. [260], they found that weight 
gain was associated with increased progression of cartilage lesions. These 
inconsistencies may be attributable to the differences in characteristics of population 
included (sample size, age, and the proportion of ROA), study design, follow-up time.  
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Interestingly, compared to previous cross-sectional or longitudinal studies on older 
populations [251-256], those studying younger population found no association 
between weight/BMI and cartilage volume [152, 250, 257]. This may reflect the 
effects of aging making knee joints more susceptible to body weight [261]. This is 
supported by our finding of significant interaction between weight and time on lateral 
cartilage volume, suggesting the effects of weight on cartilage volume was increasing 
with age. In agreement with prior studies which found more consistent detrimental 
relationships for cartilage defects [152, 153, 159, 253, 262], we found that weight was 
associated with increasing risk of medial cartilage defects. Despite the fact that this 
association became weaker with greater age, the RR of increasing weight on medial 
cartilage defects was still greater than one at 10 years. This could be attributable to 
ceiling effects on cartilage defects with age. Taken together, the current study extends 
previous observations into a long-term follow-up, and provides a strong support for 
the detrimental effects of weight gain on knee cartilage.  
Knee OA is a complex condition in which both genetic and environmental factors 
result in its development and progression [163]. There is mounting evidence to 
support the gene-environment interaction with risk of knee OA, although the 
mechanism remains unclear. In a previous study with 2-year follow-up from in this 
population, we found that smoking interacts with family history of knee OA to 
influence the susceptibility to change in knee cartilage and cartilage defect 
development [263]. A previous epidemiologic study also showed that the odds of 
having familial OA is greater in those with a higher BMI [264]. Muthuri et al. [163] 
reported that a significant interaction between overweight and transforming growth 
factor-β1 (TGF-β1) gene in the risk of knee OA. Panoutsopoulou et al. [241] found 
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that the obesity-related gene (FTO) increased the risk of OA and this association is 
mediated by BMI, indicating that FTO gene has its effects on OA solely through 
obesity. Another study based on GWAS data which investigated the genetic overlap 
between BMI and OA, further supports the conclusion that FTO gene is shared in the 
association between BMI and OA [265]. Estimated genetic ‘load’ from this study not 
only further supports genetic factors involved in the effect of BMI on cartilage 
damage, but indicates a larger effect of environmental component on cartilage 
damage (82% of the effect on cartilage damage is due to environmental component), 
and hence cartilage damage may be modifiable. Despite no current evidence of a 
genetic overlap between weight and cartilage, the current findings that the effect sizes 
of weight on cartilage volume and defects over 10 years in offspring were 
significantly and consistently higher than that in controls, together with these previous 
studies, may suggest gene-environment interaction between weight and family history 
of knee OA. Though speculative, one possible explanation may be that subtle 
alterations in extracellular matrix function attributable to genes involved in regulation 
of extracellular matrix protein in offspring, render offspring more likely to be affected 
by environmental factors, even small amounts of weight gain [123].  
The current study found that increase of weight is statistically and negatively 
associated with knee cartilage volume at the medial but not the lateral compartment in 
offspring. These results are in line with previous studies which found that weight loss 
was associated with reduction in cartilage loss at medial compartment [258, 259], 
possibly because this is the main weight-bearing site in the knee. We did observe a 
tendency towards an adverse effect of weight gain on knee cartilage volume at the 
lateral compartment which approached but did not reach statistical significance, and 
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the effect of increase of weight on lateral cartilage volume loss increases with time. It 
may be that a significant association at lateral compartment may be detectable over a 
longer time-frame. 
There are several potential limitations of this study. First, we adjusted for available 
potential confounders but we cannot rule out the influence of other knee structures 
such as BMLs and meniscal tears as T2-weighted images were not available at 
baseline. However, while adjusting for meniscal extrusion which is closely correlated 
with meniscal tears and has similar effects with meniscal tears on increased risk for 
cartilage volume loss as well as BMLs at phase 2 and 3 [232], our results remained 
largely unchanged; so it is unlikely that adjusting for these factors would change our 
results. Second, loss to follow-up may result in bias; however, there were no 
significant differences between those who completed the follow-up and the rest of the 
cohort in terms of studies factors except for a slightly higher percentage of smokers in 
those lost to follow-up. Our results did not change after using inverse probability 
weighting. Also, mixed-effect models were used for analyses which consider the 
dependence of repeated observations within participants and include the data of 
participants who were lost to follow-up. Third, our results may be influenced by 
worsening disease or co-morbidities related to weight gain over such a long period. 
Individuals with worsening disease or co-morbidities are more likely to be loss to the 
follow-up; this may underestimate our results. However, we did not screen co-
morbidities, and thus were unable to assess their influence on our results. 
In conclusion, the adverse effects of increasing weight are stronger in the offspring of 
people with knee replacement for knee osteoarthritis than that in controls without a 
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family history of knee OA suggesting genetics-environment interaction with regard to 
overweight/obesity in the pathogenesis of knee osteoarthritis particularly in the early 
stages. 
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6.1 Introduction 
OA is the most common form of arthritis in western countries [14]. The knee joint is 
the major site of OA with a prevalence of 30% in those aged 65 and above [207]. Pain 
in the knee is the most common presenting symptom of knee OA, but it also occurs 
due to other musculoskeletal diseases [266, 267]. Knee pain leads to significant 
restrictions in function that prevent OA patients from engaging in their daily activities 
[268], and may eventually require surgical treatment [269]. It is reported that 
approximately 21-35% of people aged 45 or over have had persistent knee pain 
lasting for at least one week during a month period [266, 267, 270]. Although the 
mechanism of knee pain is not fully clear, many factors have been shown to be 
associated with knee pain including demographic, structural, genetic and central 
factors (such as pain-coping strategies or beliefs about knee pain) [95, 228, 271-275].  
Factors outside knee joint structures appear to play a role in pain. Previous twin and 
sibling pair studies have demonstrated that genetic factors are involved in the 
pathogenesis of pain, with heritability estimates of approximately 50% for different 
pain traits [210, 276]. In addition, recent candidate gene studies have investigated 
gene polymorphisms associated with pain sensitivity [277-280], some of which can 
discriminate those with painful OA from those without pain. In a previous cross-
sectional report we found a higher prevalence of knee pain in  people with at least one 
parent undergoing a TKR for severe primary knee OA at baseline compared with 
controls, which was independent of structural factors, suggesting a possible role of 
genetic factors in knee pain [207]. So far, there are no studies examining if people 
with a family history of knee OA have an increased risk of knee pain over time. The 
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aims of this study were, therefore, to describe whether offspring of people who had at 
least one parent with TKR for severe primary knee OA would have an increased risk 
of worsening knee pain over 8 years as compared to controls with no family history of 
knee OA. 
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6.2 Materials and methods 
6.2.1 Participants 
This study was carried out in southern Tasmania in the capital city of Hobart. The 
initial measurements were taken from June 2000 to December 2001, a total of 372 
participants (186 offspring and 186 controls) aged 26 to 61 years (mean age of 45 
years) were enrolled. The phase two was conducted 2 years (range 1.8-2.6 years) 
later, 326 participants (162 offspring and 164 controls) were traced. The phase three 
was conducted at 10 years (range 9.1-11.4 years), 219 participants (115 offspring and 
104 controls) aged 36 to 71 years were included (Figure 6-1). Participants were 
selected from two sources, as described previously [207, 217, 219]. Half of the 
participants were the adult children (offspring) of participants who had had a TKR 
performed for primary knee OA at any Hobart hospital from 1996-2000. This 
diagnosis was confirmed by reference to the medical records of the orthopaedic 
surgeon and the original radiograph where possible. The other half were controls 
selected at random from the state Electoral Roll (2000), without a history of knee OA 
in either parent. Participants from either group were excluded on the basis of 
contraindication to MRI (including metal sutures, presence of shrapnel, iron filing in 
eye, and claustrophobia) and common rheumatoid diseases (rheumatoid arthritis and 
inflammatory arthritis). This study was approved by the Southern Tasmanian Health 
and Medical Human Research Ethics Committee and all participants provided 
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informed written consent. 
 
Figure 6-1 Participants inclusion diagram. 
6.2.2 Knee pain 
Knee pain was only assessed by self-reported pain questionnaire (yes or no pain) at 
baseline and was defined as pain for more than 24 hours in the last 12 months, or 
daily pain on more than 30 days in the last year. The WOMAC was utilized to assess 
knee pain at 2 years and 10 years. The subscales of the WOMAC which consists of 
five items (walking on flat surface, going up/down stairs, at night in the bed, 
sitting/lying and standing upright) with a 10-point scale ranging from 0 (no pain) to 9 
(most severe pain) were used for this study [281]. Each item was summed to produce 
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a total pain (0-45) score with higher scores indicating greater pain. A total of score of 
1 or greater was considered as presence of knee pain at 2 years and 10 years.  
6.2.3 Anthropometrics 
Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing 
removed) using a single pair of electronic scales (Seca Delta Model 707) calibrated 
using a known weight at the beginning of each clinic. Height was measured to the 
nearest 0.1 cm (with shoes and socks removed) using a stadiometer. BMI (kg/m2) was 
calculated. 
6.2.4 Radiographs 
A standing anteroposterior semiflexed view of the right knee was performed at 
baseline in all participants and scored individually using the Altman atlas for 
osteophytes and JSN as previously described [218]. The presence of medial or lateral 
tibiofemoral JSN or osteophytes was defined as any score of 1 or greater in that 
compartment, and 1 or greater in either for whole tibiofemoral JSN or osteophytes.  
6.2.5 Magnetic resonance imaging 
An MRI of the right knee was performed with a 1.5T whole-body magnetic resonance 
unit (Picker, Cleveland, OH, US) using a commercial transmit-receive extremity coil 
at 2 years. As previously described [40, 218], a T1-weighted fat suppression three-
dimension gradient recall acquisition and T2-weighted fat saturation two-dimensional 
fast spin echo acquisition were used. Cartilage defects were graded for medial tibial, 
medial femoral, lateral tibial, lateral femoral, and patellar sites using 0-4 point scale, 
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as previously described [217], and the scores at these five sites were summed to 
create a total score of cartilage defect. The presence of any cartilage defect was 
defined as a score of greater than 1 at any site. Effusion was assessed in the supra-
patellar pouch on T2-weighted MR images using 0-3 point scale [282], the presence 
of effusion was defined as a score of greater than 1. BMLs were assessed on T2-
weighted MRI and defined as areas of increased signal adjacent to the subcortical 
bone, as previously described [40]. The maximum area (cm2) of the lesion of different 
sites was measured, and the BML with the largest size was recorded if more than one 
lesion was present at the same site. The presence of BML was defined as a score of 
greater than 0 at any site. As previously described [216, 227], meniscal tears and 
extrusion were evaluated within 6 defined regions (anterior horn, body, and posterior 
horn of each of the medial and lateral tibiofemoral compartment) using 0-2 point 
scale. Meniscal tears and extrusion are often correlated and to ensure the least loss of 
participants [227, 232, 283], any meniscal pathology was created to be a dichotomous 
variable with a combination of them together in this study. The presence of meniscal 
pathology was defined as a score of 1 or greater of meniscal tears or extrusion at any 
site. 
6.2.6 Statistical methods 
Knee pain was assessed at baseline by simple questionnaire, not by WOMAC 
questionnaire, so change in WOMAC knee pain as the main outcome was only 
available from phase two to three. Change in WOMAC was calculated as (phase three 
value - phase two value) for total pain as well as each subscale. The smallest 
detectable difference for the WOMAC knee pain score was calculated to be 0.8 for 
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our population [284],  so an increase in score of 1 or greater was defined as the cut-off 
for worsening knee pain. Subscale-specific knee pain was defined as knee pain within 
the same subscale (for example, knee pain while walking on flat surface and change 
in knee pain while walking on flat surface). T-tests and Chi-square tests were used to 
compare differences in means and percentage where appropriate. Mann-Whitney U-
test was used to compare absolute change in knee pain between offspring and control 
group. Logistic regression modelling was used to assess the potential relationships 
between the status of participants (offspring or controls) and change in knee pain 
(increase versus no increase) over 8 years, after adjustment for age, sex, BMI, 
smoking history and knee pain at baseline. Further adjustment for structural factors of 
relevance to pain in this cohort was also performed. Inverse probability weighting 
was used to examine whether loss to follow-up biased our results. P values less than 
0.05 (2-tailed) or 95% CIs not including the “1” point were regarded as statistically 
significant. All statistical analyses were performed using SPSS Statistics (version 20; 
Chicago IL). 
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6.3 Results 
At 10 years of follow-up, a total of 219 participants comprising 115 offspring and 104 
controls completed the study. Figure 6-1 describes the study population. 207 (107 
offspring and 100 controls) had complete WOMAC pain score information at phase 
two and phase three. There were no statistically significant differences in 
characteristics of participants between the participants included in the current study 
and those lost to follow up except for history of smoking (42% versus 59%).  
The characteristics of included participants are presented in Table 6-1. Offspring were 
heavier than controls, and had a higher percentage of smokers. No significant 
differences were observed between the two groups in cartilage defects, meniscal 
pathology, effusion, BMLs and ROA. At baseline, offspring had a higher prevalence 
of knee pain, no significant difference at phase two; and a significantly higher 
prevalence at phase three compared to controls. In unadjusted analyses, offspring had 
a higher knee pain scores while walking and climbing stairs at phase two, and had a 
higher total knee pain score which approached but did not reach significance. Pain 
scores in total knee pain and each subscale were consistently greater in magnitude 
than controls at phase three.  
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Table 6-1 Characteristics of participants* 
Parameter Offspring Controls P 
Age, years 47.55 ± 6.56 47.65 ± 6.09 0.909 
Female (%) 55 61 0.386 
Height, cm 169.37 ± 8.83 167.85 ± 8.92 0.220 
Weight, kg 81.64 ± 17.90 75.93 ± 15.04 0.014 
BMI, kg/m2 28.36 ± 5.37 26.93 ± 4.99 0.049 
Previous knee injury† (%) 15 23 0.116 
Ever smoking† (%) 50 33 0.008 
Radiographic OA† (%) 17 18 0.865 
Any BML (%) 68 60 0.224 
Any cartilage defect (%) 60 50 0.149 
Any meniscal pathology (%) 20 20 0.995 
Prevalent knee pain‡ (%)    
Phase one  45 20 <0.001 
Phase two  56 54 0.764 
Phase three 74 54 0.002 
Knee pain at phase two    
Pain on flat surface 0.64 ± 1.51 0.24 ± 0.77 0.016 
Pain on stairs 1.52 ± 2.20 1.00 ± 1.48 0.044 
Pain in bed at night 0.51 ± 1.36 0.31 ± 0.97 0.211 
Pain sitting 0.43 ± 1.05 0.27 ± 0.80 0.211 
Pain standing 0.65 ± 1.56 0.35 ± 0.91 0.091 
Total pain 3.48 ± 5.97 2.17 ± 3.94 0.063 
Knee pain at phase three    
Pain on flat surface 1.16 ± 1.70 0.61 ± 1.09 0.005 
Pain on stairs 1.82 ± 2.23 1.11 ± 1.70 0.008 
Pain in bed at night 1.31 ± 2.04 0.60 ± 1.19 0.002 
Pain sitting 1.10 ± 1.69 0.56 ± 1.08 0.003 
Pain standing 1.21 ± 1.69 0.63 ± 1.09 0.003 
Total pain 6.60 ± 8.39 3.49 ± 5.51 0.001 
Bold denotes statistically significant result; BMI, body mass index; OA, osteoarthritis; BML, bone 
marrow lesion;  
*Mean ± SD except for percentages; P values determined by t-test or Pearson Chi-square test (where 
appropriate); 
†Variables were measured at phase one;  
‡Knee pain was measured by questionnaire at phase one (yes or no pain), and defined as a total of 
score of 1 or greater at phase two and phase three through WOMAC; 
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Appendices 6-1 Change in WOMAC scores between offspring and controls over 
8 years 
 
Offspring 
(n=115) 
Controls 
(n=104) 
P 
Stiffness 1.31 ± 0.33 0.74 ± 0.39 0.262 
Function 5.54 ± 1.46 4.13 ± 1.72 0.531 
Total WOMAC 10.53 ± 2.34 6.42 ± 2.66 0.246 
 
Changes in knee pain over 8 years between offspring and controls are presented in 
Figure 6-2. There were increases over time in both groups, but these were greater in 
the offspring for all categories (both changes in magnitude and increases) apart from 
knee pain on a flat surface and climbing stairs. No significant difference was found in 
change in total WOMAC and other subscales of the WOMAC (stiffness and physical 
function) (Appendices 6-1). 
Table 6-2 describes the associations between offspring-control status and risk of any 
increase in knee pain. In univariable analyses, offspring status was associated with an 
increase in total knee pain and all subscales with the exception of knee pain on a flat 
surface. In multivariable analyses, the associations between the status of participants 
and increases in knee pain remained statistically significant after adjustment for age, 
sex, BMI, smoking history and baseline knee pain. After further adjustment for 
cartilage defects, BMLs, meniscal pathology and effusion, these associations persisted 
for total knee pain and all subscales apart from knee pain on a flat surface and 
standing of which the latter was of borderline significance. Intriguingly, a trend to a 
dose-response relationship was found between the number of parent with TKR and 
Chapter 6 – Family history of knee osteoarthritis and knee pain change 
110 
 
change in total knee pain and each subscale. Numerically greater odds ratios (ORs) 
were seen in those people with two parents undergoing TKR than those offspring with 
one parent with TKR (Table 6-3). Consistent results were observed after re-analyses 
of data using inverse probability weighting. 
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Figure 6-2 Changes in knee pain between offspring and control over 8 years. (A) Absolute changes in knee pain (Mean scores); (B) The 
participants with an increase in knee pain scores of 1 or greater (%). Offspring had greater changes in knee pain scores and higher proportion of 
worsening knee pain as compared to the controls. *P< 0.05 compared with control. 
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Table 6-2 Association between offspring-control status and any increase in knee pain over 8 years 
Outcome 
Univariable analysis  Multivariable analysis†  Multivariable analysis‡  Multivariable analysis‡‡ 
OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI) 
Pain on flat surface 1.59 (0.91, 2.77)  1.74 (0.96, 3.16)  1.77 (0.93, 3.35)  1.70 (0.89, 3.25) 
Pain on stairs 2.78 (1.54, 5.04)  3.46 (1.84, 6.53)  3.39 (1.71, 6.73)  3.30 (1.66, 6.60) 
Pain in bed at night 2.27 (1.29, 3.99)  2.41 (1.31, 4.41)  2.51 (1.32, 4.78)  2.46 (1.29, 4.71) 
Pain sitting 1.99 (1.14, 3.49)  2.20 (1.20, 4.05)  2.04 (1.06, 3.90)  1.95 (1.01, 3.74) 
Pain standing 2.05 (1.16, 3.60)  2.31(1.26, 4.24)  1.90 (1.00, 3.61)  1.85 (0.97, 3.52) 
Total pain 2.32 (1.33, 4.05)  2.46 (1.35, 4.51)  2.25 (1.19, 4.26)  2.16 (1.14, 4.12) 
Bold denotes statistically result; OR odd ratio; CI confidence interval. 
†Adjusted for age, sex, body mass index, smoking, baseline pain; 
‡Further adjusted for knee injury, radiographic osteoarthritis, any cartilage defect and any bone marrow lesion; 
‡‡Further adjusted for any meniscal pathology and effusion. 
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Table 6-3 Association between the number of parent with TKR and any increase 
in knee pain 
The number of parent with TKR 
Univariable analysis  Multivariable analysis† 
OR (95% CI)  OR (95% CI) 
Pain on flat surface    
0 Ref.  Ref. 
1 1.64 (0.93, 2.88)  1.68 (0.87, 3.23) 
2 1.81 (0.35, 9.41)  2.05 (0.32, 13.25) 
Pain on stairs    
0 Ref.  Ref. 
1 2.85 (1.56, 5.20)  3.25 (1.62, 6.53) 
2 3.21 (0.61, 16.95)  4.59 (0.69, 30.77) 
Pain in bed at night    
0 Ref.  Ref. 
1 1.99 (1.13, 3.53)  2.27 (1.18, 4.38) 
2 10.78 (1.21, 96.10)  12.43 (1.22, 126.91) 
Pain sitting    
0 Ref.  Ref. 
1 1.98 (1.12, 3.50)  1.90 (0.98, 3.69) 
2 4.12 (0.72, 23.66)  2.88 (0.40, 20.74) 
Pain standing    
0 Ref.  Ref. 
1 2.03 (1.15, 3.60)  1.78 (0.93, 3.41) 
2 4.31 (0.75, 24.78)  3.63 (0.52, 25.10) 
Total pain    
0 Ref.  Ref. 
1 2.20 (1.25, 3.86)  2.15 (1.12, 4.14) 
2 2.81 (0.49, 16.05)  2.32 (0.35, 15.32) 
TKR, total knee replacement; OR, odd ratio; CI, confidence interval; Ref, reference group (control); 
†Adjusted for age, sex, body mass index, smoking, baseline pain, knee injury, radiographic OA, any 
cartilage defect, any bone marrow lesion, any meniscal pathology, and effusion. 
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6.4 Discussion 
This study found that offspring of those with severe knee OA had an increased risk of 
both prevalent pain and worsening knee pain over 8 years as compared to controls 
who had no family history of OA, and this relationship persisted after adjustment for 
potential confounding factors and for joint structural abnormalities of relevance to 
pain. This implies that the genetic contribution to knee pain may be mediated through 
factors outside the joint possibly pain processing.  
To date, there have been limited studies investigating the role of family history of 
knee OA on knee pain. Previously we reported, in a larger sample, that offspring had 
a higher prevalence of knee pain as assessed by simple questionnaire at baseline 
[207]. Consistent with this, the current study also found significant differences in 
knee pain scores (both prevalence and severity) assessed by the WOMAC at 10 years. 
Surprisingly, there was no difference in the overall prevalence of knee pain at 2 years 
although there were higher pain scores while walking on flat surface and climbing 
stairs. This variation may reflect the use of different questionnaires or more likely 
implies a greater effect on incident pain. 
Pain experience in knee OA is a complex feature, the underlying aetiology of knee 
pain is multifactorial [95].  Many earlier studies have shown that older age [266, 273, 
274], female sex [266, 285, 286], previous knee injury [287, 288] and smoking [288, 
289] appear to be important risk factors for developing knee pain. Also, overweight or 
obesity shows a causal relationship with the development of knee pain and knee OA 
[288, 290-292]. Despite structure-symptom discordance in radiographs, knee 
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structural abnormalities on MRI have been consistently associated with knee pain [26, 
95]. The present study found greater weight, more former smokers and less knee 
injury in the offspring group; however, in this study, after adjustment for these factors 
and structural factors, the association with knee pain remained largely unchanged, 
suggesting that the differences cannot be explained by these factors.  
Genetic predisposition to the development of knee pain appears important. The 
findings of present study that offspring have elevated risk of worsening knee pain, 
with around two-fold higher risk than controls for total knee pain as well as subscales 
suggest underlying genetic components in worsening knee pain. These results are 
consistent with previous twin studies [293] and earlier reports from our group which 
found the heritability of knee pain was higher in sib pairs [210]. However, whether 
family factors such as pain-coping strategies, traditions and beliefs about knee pain 
have a role is unclear [274, 294]. 
OA-related pain is a complex integration of sensory, affective, and cognitive 
processes [295], driven by both nociceptive and neurobiological mechanisms [296], 
each of which involves a number of proteins throughout the peripheral and central 
nervous systems, whose effects have been shown to be affected by the interplay 
between environmental and genetic factors [175, 293]. Several studies have 
documented that genetic mutations can confer hypersensitivity or insensitivity to pain 
stimuli [297, 298]. Therefore, it is plausible that genetic factors may have a role in the 
pain sensitivity. Recent studies have attempted to examine the relationship between 
genes associated with pain sensitivity and OA-related pain [277-279]. One study 
identified a genetic variant (Val158Met) in the catechol-O-methyltransferase (COMT) 
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gene involved in pain sensitivity to be associated with  hip pain among those with hip 
OA [277] but this was not confirmed in independent cohorts [280]. Subsequently, 
Valdes et al. [278] found allelic variation in the lle585Val variant for the gene 
encoding transient receptor potential cation channel, subfamily V, member 1 
(TRPV1) was able to discriminate those with and without painful OA. In another 
study, the single nucleotide polymorphism in the proprotein convertase 
subtilisin/kexin type 6 (PCSK6) gene also showed a strong protection against pain in 
those with knee OA [279]. When combined with the lack of clear replication for 
radiographic OA at this point in time, these studies imply that specific genes and/or 
other multiple extra-articular factors may be more important in the pathogenesis of 
knee pain than radiographic OA [95, 299], and that higher risk of worsening knee 
pain for offspring might be attributed to a difference in pain processing in the 
offspring.  
The current study has several potential limitations. First, the proportion followed up 
was 59% at 10 years, so participants lost to follow-up may lead to bias; however, re-
analyses of data using inverse probability weighting did not change any of the results, 
indicating robust results. Second, knee pain was measured using different methods, 
simple questionnaire at baseline and WOMAC at 2 years and 10 years so we are 
unable to directly compare baseline with later phases. Both methods to assess pain 
may result in recall bias due to variation in reporting of pain [300], especially for 
offspring with family history of knee OA. Third, knee pain may result from other 
musculoskeletal diseases or other sites of the body [266, 301]; however, we have not 
screened for these conditions and did not evaluate pain in other sites. Fourth, pain is a 
complex feature with multiple factors determining the report of pain. In addition to 
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genetic and structural factors, socio-economic factors such as educational level, 
occupational stress, satisfaction, and job loss, as well as psychosocial factors such as 
anxiety and depression also have a role in pain perception [302]. However, these 
factors were not measured in this study, and therefore we were unable to assess if 
these factors affect our results. Furthermore, offspring are more likely to be affected 
by family factors such as pain-coping strategies, traditions and beliefs about knee 
pain; however, these factors were not available in this study, so we cannot evaluate 
the influence of these factors. Lastly, several variables such as ROA were not 
measured at 2 years because of the perceived insensitivity of X-ray to detect 
radiological changes over this short period, it is unlikely that radiological changes 
would be different during that period. 
In summary, this longitudinal study identified offspring of people with a TKR for 
severe primary knee OA have an increased risk of worsening knee pain compared 
with controls and this relationship is independent of knee structural factors, 
suggesting that genetic factors may be involved in the pathogenesis of knee pain in 
middle life.  
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7.1 Introduction 
Musculoskeletal pain is common affecting people of all ages (particularly in the 
elderly with prevalence estimates of 10%-50%) and often occurs at multiple sites [303-
308]. A recent study showed that three quarters of those with musculoskeletal pain 
have pain at multiple sites [309]. Evidence from previous studies demonstrated that 
pain at multiple sites is associated with poorer physical and psychological health, 
worse health-related quality of life, and disability when compared to people with pain 
at a single-site [310-314].  
MSP, often defined as number of painful sites of two or more, is complex and multi-
factorial, and the underlying mechanisms remain unclear. Risk factors for MSP 
include older age [274, 304, 315], female gender [274, 306, 315], physical inactivity 
[305, 308], lower educational attainment [274, 309], unemployment [316, 317], 
psychological distress [305, 310, 315] and genetic factors [318, 319], although the 
evidence is inconsistent and may vary by site. Moreover, BMI or weight can predict 
the development of pain at different sites, indicating a possible causal relationship 
between overweight or obesity and pain [320, 321]. It has long been assumed that the 
mechanism by which overweight or obesity contributes to pain is due to increased 
physical loading; however, there is accumulating evidence to suggest a role of 
metabolic factors as obesity is linked to a low level of systemic chronic inflammation. 
Recent evidence suggests that this may be related in turn to pain [322]. Additionally, 
loading is insufficient to explaining pain occurring at non-weight bearing sites such as 
the hand [155, 308]. 
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BMI is frequently used to measure and classify obesity in the majority of studies 
investigating the association between obesity and pain; however, it cannot adequately 
disaggregate the specific components of body composition which have been found to 
have different roles in the pathogenesis of musculoskeletal diseases [323]. Fat mass is 
associated with markers of inflammation in overweight or obese individuals. More 
recently, studies have reported a specific detrimental effect of fat mass for low back 
pain [324] and foot pain [325, 326]. Few studies have examined the relationship 
between fat mass and MSP. Only limited information is available in two cross-
sectional studies [323, 327] which reported a positive association fat mass with MSP. 
Such cross-sectional studies cannot determine whether MSP precedes obesity or vice 
versa. Also, the studies did not adjust for potential confounders including socio-
demographic, physical activity and psychological factors. Therefore, the aim of this 
study was to describe cross-sectional and longitudinal associations between fat mass 
and MSP in a population-based sample of older adults, and explore the mechanisms 
underlying this relationship. 
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7.2 Patients and Methods 
7.2.1 Participants 
This study utilized data from the TASOAC, a longitudinal, observational population-
based study. A total of 1,099 participants aged 50–80 years (mean age 63 years) were 
randomly selected using computer generated random numbers from the electoral roll 
in Southern Tasmania (population 229,000), with an equal number of men and 
women. Baseline measures (Phase 1) were conducted in 2002. The follow-up 
measures were taken approximately 2.6 years (Phase 2, n=875) and 5.1 years (Phase 
3, n=768) later. The study was approved by the Southern Tasmanian Health and 
Medical Human Research Ethics Committee, and all participants provided written 
informed consent. 
7.2.2 Primary outcome measurement: pain at multi-sites 
The location of sites at which the participants experienced pain was self-reported at 
baseline, phase 2 and phase 3. Participants were asked whether they had pain (yes/no) 
in the following sites: neck, back, hands, shoulders, hips, knees or feet. The total 
number of painful sites (range 0 to 7) was categorised into four groups (no pain, 1-2, 
3-4 and 5-7 painful sites) according to the number of painful site groups with 
approximately equal numbers of participants reporting one or more painful sites 
[328].  
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7.2.3 Primary exposure measurement: body composition 
Body composition was measured at baseline, phase 2 and phase 3 by dual-energy X-
ray absorptiometry (DXA) using a Hologic Delphi densitometer (Model: Hologic 
Discovery QDR; Software: Apex system software 2.4.2; Manufacturer: Hologic, 
Waltham, MA, US), which is a quick, non-invasive scan and the gold standard in 
body composition. A DXA machine works through producing two very low dose x-
ray beams, each with different energy levels. Differences in densities of each tissue 
type lead to different levels of absorption which allow the DXA to calculate their 
relative masses [329]. Fat mass index (FMI) was calculated as: FMI=fat mass/height2. 
7.2.4 Potential covariates measurements 
7.2.4.1 Anthropometrics  
Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing 
removed) using a single pair of electronic scales (Seca Delta Model 707) calibrated 
using a known weight at the beginning of each clinic. Height was measured to the 
nearest 0.1 cm (with shoes and socks removed) using a stadiometer. Height and 
weight were measured at each time-point and were then used to calculate BMI 
(kg/m2).  
7.2.4.2 Physical activity 
Physical activity was assessed at baseline, phase 2 and phase 3 as steps/day 
determined by pedometer (Omron HJ –003 & HJ–102, Omron Healthcare, Kyoto, 
Japan), as previously described [330]. Briefly, participants were instructed to wear a 
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pedometer for seven consecutive days and to record the number of steps each day and 
the duration and type of physical activity for any activities in which the pedometer 
could not be worn (for example, swimming). This was repeated six months later to 
account for seasonal variation. Mean steps/day was calculated as the average of the 
days worn at both time points. 
7.2.4.3 Emotional problems 
Emotional problems were assessed at baseline using short form-8 Health Survey by 
asking the question: ‘how much have you been bothered by emotional problems 
during the past four weeks, such as feeling anxious, depressed or irritable?’. 
Responses included ‘not at all’, ‘very little’, ‘moderately’, ‘quite a lot’ and 
‘extremely’. The presence of emotional problems was defined as a response of ‘very 
little’ or more.  
7.2.4.4 Employment 
Employment status at baseline was self-reported and collapsed into two categories: 
employed (full/part-time) and no paid employment (home duties, student, sole 
parent/disability pension, retired or unemployed).  
7.2.4.5 Education level 
Participants reported the highest education level they had completed at baseline, 
which was collapsed into three categories: low = school only, medium = 
trade/vocational certificate, high = university level or above.  
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7.2.5 Statistical analysis 
Mean ± SD and percentages were respectively used to express the continuous and 
categorical variables, as noted. ANOVA and ordinal χ2 test (Kruskal-Wallis test) 
were used to test if there was a trend of mean of each continuous and categorical 
variable across pain groups. Longitudinal data were analysed using mixed-effects 
models that take repeated observations on participants into account and use all data on 
participants. To assess associations of total fat mass, FMI and BMI with MSP, mixed-
effect models with random intercepts for participants were used, without and with 
adjustment for factors, such as age, sex, height, smoking history, physical activity, 
emotional problems, education level and employment. Additionally, we analysed the 
associations of total fat mass, FMI and BMI with pain at each site pain after adjusting 
for the same factors to explore the mechanisms underlying the association. We tested 
for interaction between each study factor (total fat mass, FMI and BMI) and follow-
up time, but no significant interactions were found. To compare odds ratios (ORs), fat 
mass, FMI and BMI were standardised by dividing by the corresponding SD; 
therefore, all ORs represent the odds of pain associated with one SD increase in total 
fat mass, FMI or BMI. All statistical analyses were performed using Stata V.12.1 for 
windows (StataCorp, College Station, Texas, US). P values less than 0.05 (two-tailed) 
were regarded as statistically significant. 
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7.3 Results 
The participants were on average 63 years old, 51% female and had a mean BMI of 
27.9 kg/m2 at baseline. There were 768 participants participating in follow-up over 
5.1 years with three examinations contributing 2,742 person-examinations. Table 7-1 
describes the characteristics of participants at each examination. Weight, BMI, fat 
mass and FMI increased by a small amount over 5.1 years, but physical activity 
decreased markedly.  
The baseline characteristics of participants by number of painful sites are presented in 
Table 7-2. A total of 1,086 participants who had complete data on fat mass and pain 
were included into the analyses. 87% of participants had pain in at least one site, with 
28% having pain at one or two sites, 28% having pain at three or four sites, and 31% 
had pain at five or more sites. Female sex, higher weight, BMI, fat mass and FMI, 
lower levels of physical activity, having emotional problems, being unemployed and 
having lower education level were associated with reporting pain at a greater number 
of painful sites.  
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Table 7-1 Characteristics of participants at each examination* 
Characteristics 
Baseline 
(n=1099) 
Phase 2 
(n=875) 
 
Phase 3 
(n=768) 
P value 
Age, years 63.0±7.5 65.3±7.3  67.1±7.0 <0.001 
Female (%) 51 49  50 0.648 
Height (cm) 167.0±9.0 167.0±9.0  166.6±9.0 0.549 
Weight (kg) 77.9±15.0 78.1±14.8  78.1±14.8 0.922 
Body mass index (kg/m2) 27.9±4.8 28.0±4.8  28.1±4.8 0.594 
Fat mass (kg) 28.3±8.7 28.2±9.0  28.4±8.7 0.954 
Fat mass index (kg/m2) 10.3±3.6 10.3±3.7  10.4±3.7 0.854 
Ever smoking (%)† 51 NA  NA NA 
Physical activity (steps/day) 8614.9±3354.8 7405.2±3358.0  6828.4±3179.8 <0.001 
Emotional problems (%)† 64 NA  NA NA 
Employed (%)† 39 NA  NA NA 
Education level (%)†     NA 
         School only 56 NA  NA  
         Vocation training 32 NA  NA  
         University or higher 11 NA  NA  
Multi-site joint pain (%)     0.001 
         No pain  13 19  17  
         1-2 sites 29 29  31  
         3-4 sites 28 28  27  
         5-7 sites 31 24  26  
*Values are the Mean±SD except for percentages;  
†Variables were measured at baseline. 
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Table 7-2 Descriptive characteristics of participants at baseline, by number of painful 
joints* 
 Number of painful sites 
P value  0 
(n=137) 
1-2 
(n=310) 
3-4 
(n=303) 
5-7 
(n=336) 
Age, years 62.2±7.2 63.6±7.7 62.4±7.2 63.3±7.7 0.676 
Female (%) 45 48 52 57 0.005 
Height (cm) 167.4±9.0 167.6±9.4 167.4±8.6 165.9±8.8 0.028 
Weight (kg) 73.5±12.7 77.3±15.6 79.2±15.3 79.2±14.8 <0.001 
Body mass index (kg/m2) 26.2±3.9 27.4±4.5 28.2±4.5 28.8±5.3 <0.001 
Fat mass (kg) 25.0±7.1 27.5±8.5 28.8±8.1 30.0±9.5 <0.001 
Fat mass index (kg/m2) 9.1±3.0 9.9±3.4 10.4±3.3 11.1±4.1 <0.001 
Ever smoking (%) 46 51 49 55 0.104 
Physical activity (steps/day) 9495.1±3579.4 8759.4±3274.9 8560.0±3258.4 8078.2±3341.0 0.001 
Emotional problems (%) 53 56 62 70 <0.001 
Employed (%) 50 41 42 31 <0.001 
Education level (%)     <0.001 
         School only 49 55 56 61  
         Vocational training 35 31 30 34  
         University or higher 16 14 13 5  
*Values are the Mean±SD except for percentages; ANOVA and ordinal χ2 test (Kruskal-Wallis test) were used to 
test if there was a trend of mean of each continuous and categorical variable (increase or decrease) across pain 
groups.
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Figure 7-1 shows the association of fat mass and BMI with number of painful sites at 
each examination. Fat mass and BMI increased with each category of MSP. However, 
there was no statistically significant increase in fat mass or BMI over 5.1 years within 
any pain category. Similar results were seen for FMI (Figure B). 
The associations of fat mass, FMI and BMI with MSP are shown in Table 7-3. In 
univariable analysis, each SD increase in fat mass, FMI, or BMI was associated with 
increased odds of reporting MSP. The associations were reduced but remained 
statistically significant after adjusting for age, sex and height, and after further 
adjusting for smoking history, physical activity, emotional problems, education level 
and employment.  
 
Chapter 7 – Fat mass and multi-site pain 
130 
 
 
Figure 7-1 Association between fat mass/body mass index and the number of painful 
sites. Bar graph represents mean value of fat mass/body mass index, and error bars 
indicate standard deviations. P for trend determined by ANOVA test. (A) Fat mass; 
(B) Fat mass index; (C) Body mass index. 
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Table 7-3 Association between fat mass, fat mass index and body mass index and 
multi-site pain (Number of groups=1086)* 
 Univariable  Multivariable†  Multivariable‡ 
 OR 95% CI  OR 95% CI  OR 95% CI 
Fat mass 1.10 1.06, 1.14  1.08 1.04, 1.12  1.06 1.02, 1.10 
Fat mass index 1.11 1.07, 1.14  1.09 1.05, 1.13  1.07 1.03, 1.11 
Body mass index 1.09 1.05, 1.12  1.08 1.05, 1.12  1.07 1.04, 1.11 
Bold denotes statistically significant result.  
*OR (95% CI): odds ratio (95% confidence interval) representing the OR of greater number of painful 
sites associated with per SD increase in fat mass, fat mass index or body mass index; 
†Fat mass adjusted for age, sex and height; fat mass index and body mass index adjusted for age and 
sex only.
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Table 7-4 Association between fat mass, fat mass index and body mass index and site-specific pain (Number of groups=1086)* 
 Pain site Univariable  Multivariable†  Multivariable‡ 
  OR 95% CI  OR 95% CI  OR 95% CI 
Fat mass          
 Neck 1.18 0.97, 1.45  1.04 0.84, 1.29  1.00 0.80, 1.26 
 Back 1.24 1.03, 1.51  1.17 0.95, 1.44  1.20 0.97, 1.49 
 Shoulders 1.27 1.07, 1.51  1.15 0.95, 1.38  1.08 0.89, 1.31 
 Hands 1.54 1.27, 1.86  1.37 1.12, 1.67  1.29 1.04, 1.59 
 Hips 1.53 1.27, 1.84  1.41 1.16, 1.71  1.38 1.13, 1.70 
 Knees 1.96 1.61, 2.39  1.98 1.61, 2.44  1.99 1.59, 2.49 
 Feet 1.89 1.56, 2.28  1.79 1.46, 2.18  1.87 1.51, 2.32 
Fat mass index          
 Neck 1.28 1.05, 1.57  1.05 0.83, 1.33  1.00 0.78, 1.28 
 Back 1.29 1.06, 1.57  1.20 0.95, 1.50  1.22 0.95, 1.56 
 Shoulders 1.39 1.16, 1.65  1.19 0.97, 1.46  1.10 0.88, 1.37 
 Hands 1.73 1.43, 2.11  1.47 1.18, 1.84  1.37 1.08, 1.73 
 Hips 1.62 1.34, 1.95  1.47 1.18, 1.82  1.42 1.13, 1.79 
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Bold denotes statistically significant result.  
*OR (95% CI): odds ratio (95% confidence interval) representing the OR of greater number of painful sites associated with per SD increase in fat mass, fat mass index or 
body mass index; 
†Fat mass adjusted for age, sex and height; fat mass index and body mass index adjusted for age and sex only. 
‡Further adjusted for smoking history, physical activity, emotional problems, education level and employment; 
 
 Knees 1.86 1.53, 2.27  2.07 1.64, 2.61  2.06 1.60, 2.64 
 Feet 1.95 1.61, 2.36  1.90 1.52, 2.37  1.99 1.57, 2.53 
Body mass index          
 Neck 1.10 0.90, 1.36  1.09 0.89, 1.34  1.06 0.86, 1.31 
 Back 1.23 1.01, 1.50  1.23 1.01, 1.49  1.25 1.02, 1.54 
 Shoulders 1.21 1.02, 1.44  1.20 1.01, 1.42  1.14 0.95, 1.37 
 Hands 1.48 1.22, 1.79  1.46 1.20, 1.77  1.41 1.15, 1.72 
 Hips 1.49 1.23, 1.79  1.46 1.22, 1.76  1.45 1.20, 1.76 
 Knees 1.95 1.60, 2.38  1.94 1.59, 2.37  1.94 1.57, 2.40 
 Feet 1.77 1.46, 2.14  1.75 1.45, 2.12  1.84 1.50, 2.26 
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Table 7-4 presents the associations of fat mass, FMI and BMI with presence of pain at 
each site. In univariable and multivariable analysis adjusting for the same 
confounders as for MSP, greater fat mass was associated with greater odds of pain in 
lower limbs (knees, hips and feet) and hands. Results were similar with FMI and BMI 
as the outcome, but BMI was also associated with increased odds of back pain. There 
were no statistically significant associations between measures of fat mass and pain at 
the neck or shoulders in multivariable analysis. 
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7.4 Discussion 
This study shows that fat mass, FMI and BMI are associated with MSP, pain at 
weight-bearing sites and hand pain. These relationships are independent of 
demographic factors, physical activity, psychological health, education level and 
employment, suggesting that fat mass may play an important independent role in the 
pathogenesis of MSP. This may reflect a role of systemic inflammatory factors in 
joint pain as one would not expect to observe significant association of fat mass with 
hand pain. 
The high prevalence of pain at multiple sites is consistent with that reported in 
previous studies [301, 305, 309, 315, 323, 331-334], and confirms that MSP is 
extremely prevalent in a community-based older population. However, some prior 
studies have found greater prevalence of MSP than that found in our study. These 
discrepancies may be attributed to the difference in the characteristics of the 
population studied, definition of MSP and number of painful sites assessed. Our 
results also showed that the prevalence of MSP with more than two painful sites did 
not change much over time in the whole population with slightly over half at each 
visit. This suggests that MSP is likely to be relatively stable once established [304].  
The findings that fat mass, FMI and BMI are associated with increased risk of pain at 
multiple sites indicates a substantial effect of fat mass or body weight on the 
pathogenesis of MSP. Our findings not only add further evidence to support the 
significant role of fat mass in pain, but extend previous cross-sectional studies to 
longitudinal analyses with a large dataset. Our results are consistent with previous 
studies in which BMI was used to examine the association between 
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overweight/obesity and MSP. In a recent longitudinal study performed in the general 
population, Magnusson et al. [321] found that overweight/obesity increased the odds 
of reporting MSP. Kamaleri et al. [310] found a greater number of painful sites 
reported in those with a higher BMI. However, the specific components of body 
composition cannot be distinguished in these studies. Currently, there are only two 
cross-sectional studies investigating the relationship between body composition and 
MSP. Brady et al. [323] reported that fat mass is associated with an increased number 
of lower body pain sites (low back, knee and foot), and Yoo et al. [327] found fat 
mass to be positively associated with widespread pain. 
The potential mechanisms that may link obesity-related pain are most likely physical 
loading and metabolic effects [308]. Our results showed that fat mass, FMI and BMI 
are associated with pain at all weight-bearing sites. This is consistent with previous 
studies reporting associations between fat mass and single-site pain [325, 326, 335]. 
These suggest a potential involvement of biomechanical mechanisms, as excess 
loading may result in changes in body mechanics, postures or abnormal gait, thus 
creating a detrimental biomechanical environment [336]. However, the finding of a 
significant association of fat mass, FMI and BMI with hand pain indicates a potential 
role for metabolic effects in the pathogenesis of pain, since physical loading is not 
adequate to explaining pain occurring at non-weight bearing sites [320, 337]. It has 
been recognized that adipose tissue is serving as an endocrine organ to produce 
proinflammatory cytokines and adipokines [338]. An increased level of cytokines and 
inflammatory markers, such as C-reactive protein (CRP), Interleukins-6 (IL-6), TNF-
alpha (TNF-α) and Leptin observed in obese individuals has been reported in prior 
studies [339, 340]. Recent evidence suggests that inflammation can lead to a lowering 
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of excitation threshold and enhanced responses to suprathreshold stimuli of peripheral 
nociceptors (peripheral sensitisation) [95], and subsequently developing central 
nervous system sensitisation with pain hypersensitivity and increased vulnerability to 
reporting more pain sites [341]. It is therefore possible that individuals with greater 
fat mass are more likely to have peripheral or central sensitisation in relation to 
elevated level of systemic inflammation, thereby leading to a greater number of 
painful sites. 
The current study was unable to detect a significant association between fat mass, 
FMI and BMI, and neck and shoulder pain, suggesting that neck and shoulder pain are 
not related to fat mass regardless of the mechanism. Consistent with this, Iizuka et al. 
[342] found no association between fat mass and neck and shoulder pain and 
concludes that neck and shoulder pain may be manifest through muscle dysfunction. 
This is supported by reported altered muscle activation patterns in patients with 
neck/shoulder pain with increased activation of upper trapezius and reduced 
activation of serratus anterior [343]. BMI, but not other measures of fat mass, was 
associated with back pain. The reasons for this remain unclear. Overall, the 
magnitude of the effect per SD increase for fat mass, FMI and BMI were similar for 
all pain sites, suggesting that DXA derived fat mass is not superior to BMI for 
accounting for musculoskeletal outcomes. 
The current study found that the relationship between fat mass and MSP remained 
significant after adjusting for age, sex, height, physical activity, education level, 
employment, and psychological distress, suggesting that the associations with fat 
mass cannot be fully explained by these factors even if they were themselves 
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associated with pain. Previous studies have demonstrated that body fat [344] and pain 
[345] are substantially influenced by underlying genetic factors, so it is possible that 
genetic factors may underlie these associations. This is supported by a recent meta-
analysis [346], in which pooling of the results from five twin studies on the 
relationship between obesity and low back pain showed a positive relationship 
between BMI or weight and low back pain, but the relationship diminished after 
adjusting for shared genetic factors, suggesting that genetic factor may be mediating 
the association.  
Limitations of our study include the use of a self-reported questionnaire, which was 
simple (yes/no) and did not include assessment of frequency, severity, and quality of 
pain. We, therefore, cannot evaluate whether fat mass is associated with intensity and 
different types of pain. Additionally, assessments were made on only three occasions 
over 5.1 years – more frequent observations may allow more information on temporal 
patterns in fluctuations in pain. Another limitation is that the participants were 
recruited from one center, which may not be generalisable to other populations as 
previous studies have indicated that special cultural and socioeconomic conditions 
may determine individual perceptions affecting the report of pain [319, 347]. 
Furthermore, although socio-demographic and psychological factors were considered 
in this study, we cannot exclude the influence of unmeasured factors, such as pain 
coping strategies. Finally, although fat mass is often considered as a surrogate for 
systemic inflammation, inflammatory markers were not analysed directly in this 
study. Accordingly, further investigation into the role of inflammatory markers in the 
pathogenesis of MSP is warranted. 
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There are several implications raised from the findings of this study. First, 
overweight/obese individuals with MSP may benefit from weight loss either via 
exercise, diet or bariatric surgery. Therefore, the general practitioner should introduce 
weight management programs involving exercise and diet to overweight/obese 
individuals and encourage them to change their lifestyles to lose weight, although 
there is a considerable challenge in the maintenance of weight loss in the long-term. 
Second, the mechanisms by which overweight/obesity contributes to pain may be not 
only related to increased physical loading, but also elevated systemic inflammation; 
thus, facilitating potential therapeutic targets for obesity-related pain. For instance, 
the administration of drugs with pleiotropic actions (anti-inflammatory and those 
blocking cholesterol biosynthesis, such as statins) may help to attenuate pain 
induction in clinical setting; this would need to be tested in a future clinical trial. 
To sum up, fat mass, FMI and BMI are associated with MSP, pain at all lower limb 
sites and hand pain, independent of socio-demographic, physical activity and 
psychological factors, suggesting that obesity appears to be an important factor in the 
pathogenesis of fat-related MSP. The potential mechanisms underlying the 
relationship between fat mass and MSP may be via loading and systemic 
inflammatory factors. 
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Chapter 8: Pain at sites outside the knee predicts knee 
cartilage volume loss in elderly people without knee 
osteoarthritis: a prospective study  
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8.1 Introduction 
Musculoskeletal pain commonly occurs in older people, with knees the most 
commonly reported painful site. Joint pain is associated with functional limitation and 
impaired quality of life [14] and the primary reason why people seek help with knee 
OA [95]. Isolated knee pain is uncommon in the elderly but rather knee pain is 
typically accompanied by pain at other sites [311, 312, 348]. Compared to single-site 
pain, MSP is associated with poorer level of physical and psychological health, worse 
health-related quality of life, and more severe depressive symptoms in both cross-
sectional and longitudinal studies [311, 312, 314]. 
A number of studies have investigated associations between knee pain and 
development and progression of knee OA [252, 349-351]. There is no evidence for an 
association between knee pain and progression of radiographic knee OA based on a 
previous meta-analysis [352]. Previous studies have demonstrated that loss of 
cartilage, a major hallmark of OA, is predictive of clinically relevant endpoint of knee 
replacement [17, 27, 28]; however, studies of the associations between knee pain and 
knee cartilage volume loss are inconsistent [245, 252, 255, 349-351]. In a 2-year 
longitudinal study, Cicuttini et al. [349] reported that knee pain at baseline was 
associated with greater patella cartilage volume loss. A study with a 4.5-year follow-
up reported that knee pain was associated with a higher rate of medial tibial cartilage 
volume loss [252]. Saunders et al. [350] found that knee pain independently predicted 
lateral but not medial tibial cartilage volume loss in a 2.9-year follow-up study. In 
addition, people with frequent knee pain had greater medial tibiofemoral cartilage 
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volume loss than those without [351], while Raynauld et al. [245] and Wluka et al. 
[255] did not find any associations between knee pain and change in cartilage volume.  
One possible explanation for these inconsistent results is that studies to date have not 
taken pain at other sites into account. This is important as MSP may be due to higher 
levels of disease activity, such as systemic factors, dysfunction in central pain 
processing, or genetic factors [353-357], and thus may represent a different phenotype 
of pain from single-site pain. The prevalence of those with detectable levels of 
systemic inflammation was not low in the general population [322]. Furthermore, OA 
is the most common cause of pain in the elderly; therefore, people with MSP most 
likely represent the disease activity of OA in a general population. Potential risk 
factors for knee cartilage volume loss reported in previous studies include older age 
[358], female sex [358], BMI [150], relevant knee structural abnormalities [26] and 
genetic factors [359]. Studies that attempt to investigate the relationship between 
MSP and cartilage volume loss should assess the effect of these potential factors. 
Therefore, this study aimed to determine whether MSP is a predictor of knee cartilage 
volume loss, and if so, to explore potential mechanisms. 
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8.2 Patients and Methods 
8.2.1 Participants 
This study was conducted as part of the TASOAC-a longitudinal, observational 
population-based study. The cohort consisted of both men and women and was 
selected from the electoral roll in Southern Tasmania generated by staff of the 
Tasmanian Electoral office on 31st January 2002 (total number of people on the roll 
n=229,593) using sex-stratified simple random sampling without replacement. The 
eligible cohort consisted of registered electors aged 50–80 years (n=61,715, 
men/women=29,484/32,231). Institutionalised older adults were excluded because 
TASOAC was designed to study community-dwelling older adults. A total of 2,530 
subjects were selected from the roll using 5-year age band information with equal 
number of men and women. Among them, 395 were deemed unable to participate due 
to illness or other reasons, and the remainder were contacted via mail by asking 
whether they would like to participate in the study. Of 2,135 subjects, 1,100 were 
enrolled in the study and 1,099 attended the first clinic between March 2002 and 
September 2004 (response rate 57%) at the Menzies Institute for Medical Research, 
Australia. The follow-up measures were taken approximately 2.6 years (range 1.4–4.8 
years) later (n=875) (retention rate 80%). MRI scans were available for only 
approximately half of the follow-up participants (n=425 of 875). The current study 
consists of a sample of 394 TASOAC participants who had MRI measures at baseline 
and follow-up and data on pain at baseline. The study was approved by the Southern 
Tasmanian Health and Medical Human Research Ethics Committee (Ref. no: 
H0006488), and all participants provided informed written consent. 
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8.2.2 Primary outcome measurement 
8.2.2.1 Knee cartilage volume 
MRI scans of the right knee were performed at baseline and after 2.6 years. Knee 
cartilage volume was determined by means of image processing on an independent 
work station using Osiris (University of Geneva) and measured by two trained and 
blinded observers as previously described [243]. The volumes of individual cartilage 
plates (medial tibia and lateral tibia) were isolated from the total volume by manually 
drawing disarticulation contours around the cartilage boundaries on a section by 
section basis. These data were then resampled by means of bilinear and cubic 
interpolation for the final three-dimensional rendering. The CV for baseline and 
follow-up cartilage volume measures was 2.1% for medial tibial, and 2.2% for lateral 
tibial cartilage [243]. Knee femoral cartilage volume was determined by means of 
image processing on an independent workstation using Cartiscope ™ (ArthroVision 
Inc., Montreal) , as previously described [245]. The segmentation of the cartilage-
synovial interfaces was carried out with the semi-automatic method under reader 
supervision and with corrections when needed. Cartilage volume was evaluated 
directly from a standardized view of three-dimensional cartilage geometry as the sum 
of elementary volumes. The CV was approximately 1.6% for medial femoral and 
2.9% for lateral femoral cartilage at baseline and follow-up [245]. The cartilage 
volume assessment was done for the medial and lateral condyles delineated by the 
Blumensaat’s line. The medial, lateral and total tibiofemoral cartilage volume created 
for this study were the sum of cartilage volume of corresponding sites. Rates of 
change in cartilage volume were calculated as: percentage change per annum = [100 × 
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((follow-up cartilage volume - baseline cartilage volume)/baseline cartilage 
volume)/time between two scans in years]. 
8.2.3 Primary exposure measurement 
8.2.3.1 Multiple-site pain 
The location of sites at which the participants experienced pain was measured by self-
reported questionnaire at baseline. Participants were asked whether they had pain 
(yes/no) in the following sites at present: neck, back, hands, shoulders, hips, knees or 
feet. The number of painful sites was summed to create a total number of painful site 
with a range from 0 to 7, which was then categorised into four groups (non-painful 
site, 1-2, 3-4, 5-7 painful sites) according to the number of painful site groups with 
approximately equal numbers of participants reporting one or more painful sites 
[328]. Number of painful site types was also assessed on a regional basis, with total 
count of painful upper limb sites created by summing the number of painful upper 
limb sites (neck, hands and shoulders, range 0–3), and count of painful lower limb 
sites created by summing number of hip, knees and feet (range 0–3). 
8.2.4 Measurement of potential covariates 
8.2.4.1 Anthropometrics  
Weight was measured to the nearest 0.1 kg (with shoes, socks and bulky clothing 
removed) using a single pair of electronic scales (Seca Delta Model 707) calibrated 
using a known weight at the beginning of each clinic. Height was measured to the 
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nearest 0.1 cm (with shoes and socks removed) using a stadiometer. BMI (kg/m2) was 
calculated.  
8.2.4.2 Physical activity 
Physical activity was assessed at baseline as steps/day determined by pedometer. 
Each participant was instructed to wear a pedometer for seven consecutive days and 
to record the number of steps each day and the duration and type of physical activity 
for any activities in which the pedometer could not be worn (for example, 
swimming). This was repeated six months later to account for seasonal variation. 
Mean steps/day was calculated as the average of the days worn at both time points. 
8.2.4.3 Use of pain medication 
Participants were asked to list all medication prescribed by a doctor, and any other 
over-the-counter medications they had taken in the last two weeks, including dosage 
and frequency. Medications used for pain relief were extracted from this list, and 
dichotomised into whether they were used or not (yes/no). 
8.2.4.4 Radiographs 
A standing anteroposterior semiflexed view of the right knee was performed in all 
participants and scored individually using the Altman atlas for osteophytes and JSN 
on a scale of 0-3 [360]. The presence of medial or lateral tibiofemoral JSN or 
osteophytes was defined as any score of 1 or greater in that site, and 1 or greater in 
either for whole tibiofemoral JSN or osteophytes. The presence of ROA was defined 
as any score ≥ 1 for JSN or osteophytes. 
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8.2.4.5 Cartilage defects 
Cartilage defects were assessed at baseline on T1-weighted MR images at the medial 
tibial, medial femoral, lateral tibial, and lateral femoral sites, as previously described 
[247], as follows: grade 0 = normal cartilage; grade 1 = focal blistering and 
intracartilaginous low-signal intensity area with an intact surface and base; grade 2 = 
irregularities on the surface or base and loss of thickness < 50%; grade 3 = deep 
ulceration with loss of thickness > 50%; and grade 4 = full-thickness chondral wear 
with exposure of subchondral bone. The ICCs ranged from 0.80–0.95 for intra-
observer repeatability. The presence of any cartilage defect was defined as a score of 
≥ 2 at any site. 
8.2.4.6 Bone marrow lesions 
BMLs were assessed at baseline on T2–weighted MR images and defined as areas of 
increased signal adjacent to the subcortical bone at the medial tibial, medial femoral, 
lateral tibial, and lateral femoral sites, as previously described [45]. The maximum 
area (mm2) of the lesion of different sites was measured, and the BML with the 
largest size was recorded if more than one lesion was present at the same site. The 
presence of any BML was defined as a score of greater than 0 at any site. The ICC 
was 0.97 for intra- observer repeat-ability. 
8.2.5 Statistical analysis 
T-tests and Chi-square were used to compare differences in means and percentages 
between the participants included and the rest of cohort where appropriate. ANOVA 
and ordinal χ2 test (Kruskal-Wallis test) were used to test if there was a trend of mean 
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of each continuous and categorical variable across pain groups. Cartilage volume 
(either at baseline or % change) was normally distributed in this sample; therefore, 
linear regression was used to assess the potential associations between the number of 
painful sites and cartilage volume loss (% per annum), before and after adjustment for 
age, sex, BMI, physical activity, pain medication, baseline cartilage volume, cartilage 
defects, BMLs, JSN and osteophytes. Significant interactions between the number of 
painful sites and knee ROA were detected, suggesting that the effect of the number of 
painful site on cartilage volume loss was different in participants with and without 
ROA. Subgroup analyses according to ROA status were therefore performed. We also 
performed the analyses on the associations between pain at each specific site and 
cartilage volume loss using linear regression to explore the mechanisms underlying 
these associations. Sensitivity analyses were performed using inverse probability 
weighting to determine whether loss to follow-up biased our results. Multiple 
comparisons on the results of associations between site-specific pain and cartilage 
volume loss were controlled using the Hochberg method [224]. All statistical analyses 
were performed using Stata V.12.1 (StataCorp, US). 
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8.3 Results 
In the current study, 394 of 1,099 participants with MRI measures at baseline and 
follow-up and pain measures were included. The average follow-up time was 2.6 
years (range 1.4–4.8). 705 participants were excluded from this study due to loss to 
follow-up or no data on the MRI and pain. There were no significant differences in 
age, sex, BMI, physical activity, pain medication, ROA, BMLs as well as the number 
of painful sites between the participants included (n=394) and the rest of cohort 
(n=705), except for a slightly higher prevalence of medial tibiofemoral cartilage 
defects in those who were not included in this study. 
Table 8-1 presents the baseline characteristics of participants by category of number 
of painful sites. The median number of painful sites was 3 (range 0 to 7) and 87% of 
participants had pain at least one site. Among them, 115 (29%) reported having pain 
at one or two sites; 110 (28%) had three or four painful sites and 119 (30%) reported 
pain at five or more sites. Participants reporting a greater number of painful sites were 
more likely to be women, have higher BMI, higher reported use of pain medication, 
and a trend to less physical activity. There were no baseline differences in the 
proportion of participants with ROA, cartilage defects, BMLs and baseline cartilage 
volume. Increasing number of painful sites was associated with cartilage volume loss 
over 2.6 years in the lateral and total tibiofemoral compartments with higher rate of 
cartilage volume loss in participants reporting pain in greater numbers of painful sites. 
There was also a tendency towards increased medial tibiofemoral cartilage volume 
loss as number of painful sites increased (Table 8-1and Figure 8-1).  
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Table 8-1 Descriptive characteristics of participants at baseline, by number of 
painful sites* 
 Number of painful sites 
P 
value 
 0 
(N=50) 
1-2 
(N=115) 
3-4 
(N=110) 
5-7 
(N=119) 
Age, years 62.2±7.6 64.6±8.0 62.3±6.3 62.6±7.0 0.676 
Female (%) 44 40 57 72 0.005 
Body mass index 
(kg/m2) 
26.5±4.4 27.1±4.1 27.9±4.4 28.4±4.8 <0.001 
Physical activity 
(steps per day) 
9849.4±4090.6 8677.3±2940.5 8588.3±2933.8 8486.2±3407.4 <0.001 
Any pain medication 
(%) 
43 47 56 74 <0.001 
Radiographic knee 
OA (%) 
61 52 61 61 0.151 
Any knee cartilage 
defects (%) 
24 32 31 33 0.176 
Any knee BMLs (%) 42 42 45 45 0.583 
Cartilage volume at 
baseline (ml) 
     
MTF 6.3±1.5 6.4±1.7 6.4±1.5 6.1±1.6 0.324 
LTF 7.1±1.7 7.3±1.9 7.3±1.6 6.8±1.7 0.190 
TF 13.4±3.1 13.8±3.5 13.7±3.1 13.0±3.3 0.235 
Percentage change 
in cartilage volume 
(per annum) 
     
MTF -1.3±2.8 -1.3±2.3 -1.8±2.5 -2.0±2.7 0.040 
LTF -0.9±2.2 -1.1±1.7 -1.5±2.1 -1.8±2.2 0.003 
TF -1.1±2.3 -1.2±1.7 -1.7±2.1 -2.0±2.0 0.004 
Bold denotes statistically significant result; OA osteoarthritis; BMLs bone marrow lesions; MTF 
medial tibiofemoral compartment; LTF lateral tibiofemoral compartment; TF tibiofemoral 
compartment; 
*Values are the Mean±SD except for percentages; ANOVA and ordinal χ2 test (Kruskal-Wallis test) 
were used to test if there was a trend of mean of each continuous and categorical variable (increase or 
decrease) across pain groups.  
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Figure 8-1 The association between number of painful sites and cartilage volume loss 
in the total sample. With increasing number of painful sites, there is greater annual 
cartilage volume loss at lateral and total, but not at medial tibiofemoral compartment. 
The β coefficients and P values are from tests of trend of cartilage volume loss on 
number of painful sites determined by linear regression. *represents the univariable 
analysis; #represents multivariable analysis with adjustment for age, sex, body mass 
index, physical activity, pain medication, baseline cartilage volume, cartilage defects, 
bone marrow lesions, joint space narrowing and osteophytes for corresponding 
compartment. MTF medial tibiofemoral compartment; LTF lateral tibiofemoral 
compartment; TF tibiofemoral compartment. 
Figure 8-1 describes the association between the number of painful sites and cartilage 
volume loss. In unadjusted analyses, cartilage volume loss increased with greater 
numbers of painful sites in a dose-response manner at all compartments (medial, 
lateral and total tibiofemoral compartments). After adjustment for age, sex, BMI, 
physical activity, osteophytes, JSN, cartilage defects and BMLs, these significant 
associations persisted at lateral (β=-0.28% per annum, 95% CI -0.52%, -0.03%, 
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P=0.030) and total (β=-0.25% per annum, 95% CI -0.49%, -0.01%, P=0.046) 
tibiofemoral compartments. In the medial tibiofemoral compartment, the magnitude 
of the effect was only slightly less (β=-0.20% per annum) and did not reach statistical 
significance (P=0.191), but it showed a similar pattern with lateral and total 
tibiofemoral cartilage volume loss.  
There was a significant interaction between number of painful sites and ROA status 
for lateral and total tibiofemoral cartilage volume loss, and thus subgroup analysis 
was conducted by the status of ROA. Table 8-2 and Table 8-3 show the results of 
association of number of painful sites and lateral and total tibiofemoral cartilage 
volume loss stratified by ROA status using “non-painful site” as a reference group. 
The significance of a linear trend was tested using Wald tests and there was a trend if 
P<0.05. For those without ROA, we found that having 1-2, 3-4 and 5-7 painful sites 
had greater cartilage volume loss in the fully adjusted model, and showed a dose-
response relationship for lateral and total tibiofemoral cartilage volume loss (adjusted 
P for trend=0.002). However, we did not observe any significant associations or dose-
response relationship in participants with ROA. 
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Table 8-2 Association between the number of painful sites and lateral tibiofemoral cartilage volume loss, by ROA status 
 No. of pain 
sites 
Annual percentage Univariable  Multivariable† 
 cartilage volume loss (mean, %) β 95% CI  β 95% CI 
Without ROA        
 0 -0.41 Ref.   Ref.  
 1-2 -1.00 -0.59 -1.67, 0.50  -0.73 -1.84, 0.39 
 3-4 -1.69 -1.28 -2.43, -0.14  -1.37 -2.52, -0.22 
 5-7 -1.96 -1.55 -2.67, -0.44  -1.71 -2.92, -0.49 
 P for trend   0.001   0.002 
With ROA 0 -1.10 Ref.   Ref.  
 1-2 -1.19 -0.09 -1.29, 1.11  0.18 -0.99, 1.36 
 3-4 -1.38 -0.28 -1.45, 0.89  -0.02 -1.19, 1.15 
 5-7 -1.73 -0.63 -1.79, 0.53  -0.16 -1.39, 1.06 
 P for trend   0.201   0.635 
Bold denotes statistically significant result. β regression coefficient; CI confidence interval; ROA radiographic osteoarthritis; Ref reference group; 
†Adjusted for age, sex, body mass index, physical activity, any pain medication, baseline lateral cartilage volume, cartilage defects and bone marrow lesions. 
 
Chapter 8 – Multi-site pain and knee cartilage volume loss 
154 
 
Table 8-3 Association between the number of painful sites and total tibiofemoral cartilage volume loss, by ROA status 
 No. of pain 
sites 
Annual percentage Univariable  Multivariable† 
 cartilage volume loss (mean, %) β 95% CI  β 95% CI 
Without ROA        
 0 -0.34 Ref.   Ref.  
 1-2 -0.97 -0.63 -1.70, 0.43  -0.82 -1.94, 0.30 
 3-4 -1.97 -1.63 -2.76, -0.51  -1.66 -2.83, -0.50 
 5-7 -1.76 -1.42 -2.52, -0.32  -1.69 -2.90, -0.48 
 P for trend   0.003   0.002 
With ROA        
 0 -1.48 Ref.   Ref.  
 1-2 -1.45 0.04 -1.13, 1.20  0.27 -0.87, 1.41 
 3-4 -1.52 -0.03 -1.16, 1.11  0.33 -0.80, 1.47 
 5-7 -2.08 -0.60 -1.73, 0.53  0.02 -1.16, 1.20 
 P for trend   0.204   0.930 
Bold denotes statistically significant result. β regression coefficient; CI confidence interval; ROA radiographic osteoarthritis; Ref reference group; 
†Adjusted for age, sex, body mass index, physical activity, any pain medication, baseline cartilage volume, cartilage defects and bone marrow lesions. 
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Further analyses using linear regression on the association between pain at each 
specific site and total tibiofemoral cartilage volume loss to explore whether weight 
bearing or systemic factors underlies the associations. As shown in Table 8-4, hand, 
shoulder and back pain showed statistically significant associations with cartilage 
volume loss in those without (but not with) ROA after adjustment for confounders, 
but pain at all lower limb sites was not associated with cartilage volume loss. The 
significant associations remained after adjusting for multiple testing (Table 8-4). 
Consistent results were found after further adjustment for knee injury and common 
comorbidities including diabetes, heart problems, hypertension, and rheumatoid 
arthritis, and even mutual adjustment for pain at other sites as well as after re-analyses 
of data using inverse probability weighting method (Appendices 8-1 and Appendices 
8-2). 
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Table 8-4 Association between pain at each site and total tibiofemoral cartilage 
volume loss, by ROA status 
 Pain 
site 
Univariable  Multivariable† 
 β 95% CI  β 95% CI 
Without ROA       
 Neck -0.57 -1.22, 0.07  -0.67 -1.37, 0.03 
 Hand -0.83 -1.47, -0.19
‡
  -0.83 -1.52, -0.13
‡
 
 Shoulder -0.78 -1.42, -0.14
‡
  -0.81 -1.50, -0.13
‡
 
 Back -0.52 -1.17, 0.13  -0.83 -1.50, -0.17
‡
 
 Knee -0.54 -1.20, 0.13  -0.55 -1.22, 0.12 
 Hip -0.30 -0.95, 0.34  -0.47 -1.14, 0.20 
 Foot -0.50 -1.16, 0.16  -0.22 -0.92, 0.47 
 Upper limb -0.38 -0.62, -0.14
‡
  -0.47 -0.72, -0.21
‡
 
 Lower limb -0.28 -0.58, 0.02  -0.27 -0.58, 0.04 
With ROA       
 Neck -0.37 -1.08, 0.33  -0.09 -0.78, 0.60 
 Hand 0.00 -0.71, 0.71  0.17 -0.53, 0.87 
 Shoulder -0.59 -1.33, 0.14  -0.43 -1.15, 0.29 
 Back -0.52 -1.24, 0.21  -0.22 -0.96, 0.52 
 Hip 0.10 -0.61, 0.82  0.28 -0.46, 1.02 
 Knee -0.37 -1.07, 0.33  -0.02 -0.74, 0.71 
 Foot -0.05 -0.76, 0.67  0.23 -0.50, 0.95 
 Upper limb -0.18 -0.43, 0.07  -0.07 -0.33, 0.19 
 Lower limb -0.09 -0.43, 0.25  0.10 -0.27, 0.48 
Bold denotes statistically significant result. β regression coefficient; CI confidence interval; ROA 
radiographic osteoarthritis; Ref reference group; 
†Adjusted for age, sex, body mass index, physical activity, any pain medication, baseline cartilage 
volume, cartilage defects and bone marrow lesions; 
‡Denotes significant association that passes Hochberg adjustment for multiple testing. 
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Appendices 8-1 Association of the number of pain sites with lateral and total 
tibiofemoral cartilage volume loss in those without ROA 
 No. of pain 
sites 
Multivariable†  Multivariable‡ 
 β 95% CI  β 95% CI 
Lateral tibiofemoral cartilage volume 
loss 
      
 0 Ref.   Ref.  
 1-2 -0.73 -1.84, 0.39  -0.72 -1.85, 0.41 
 3-4 -1.37 -2.52, -0.22  -1.23 -2.43, -0.03 
 5-7 -1.71 -2.92, -0.49  -1.71 -2.95, -0.46 
 P for trend  0.002   0.003 
Total tibiofemoral cartilage volume loss 0 Ref.   Ref.  
 1-2 -0.82 -1.94, 0.30  -0.81 -1.94, 0.32 
 3-4 -1.66 -2.83, -0.50  -1.55 -2.76, -0.33 
 5-7 -1.69 -2.90, -0.48  -1.67 -2.91, -0.43 
 P for trend  0.002   0.003 
Bold denotes statistically significant result. β regression coefficient; CI confidence interval; ROA 
radiographic osteoarthritis; Ref reference group; 
†Adjusted for age, sex, body mass index, physical activity, any pain medication, baseline cartilage 
volume, cartilage defects and bone marrow lesions; 
‡ Further adjusted for knee injury, diabetes, heart problems, hypertension, and rheumatoid arthritis. 
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Appendices 8-2 Association between pain at each site and total tibiofemoral 
cartilage volume loss, by ROA status 
 Pain 
site 
Multivariable†  Multivariable‡ 
 β 95% CI  β 95% CI 
Without ROA       
 Neck -0.67 -1.37, 0.03  -0.61 -1.33, 0.10 
 Hand -0.83 -1.52, -0.13  -0.74 -1.43, -0.06 
 Shoulder -0.81 -1.50, -0.13  -0.73 -1.42, -0.04 
 Back -0.83 -1.50, -0.17  -0.75 -1.42, -0.09 
 Knee -0.55 -1.22, 0.12  -0.40 -1.07, 0.28 
 Hip -0.47 -1.14, 0.20  -0.30 -0.97, 0.37 
 Foot -0.22 -0.92, 0.47  -0.15 -0.83, 0.54 
 Upper limb -0.47 -0.72, -0.21  -0.43 -0.77, -0.09 
 Lower limb -0.27 -0.58, 0.04  -0.16 -0.41, 0.09 
With ROA       
 Neck -0.09 -0.78, 0.60  -0.20 -0.93, 0.53 
 Hand 0.17 -0.53, 0.87  0.08 -0.65, 0.81 
 Shoulder -0.43 -1.15, 0.29  -0.56 -1.30, 0.19 
 Back -0.22 -0.96, 0.52  -0.38 -1.17, 0.41 
 Hip 0.28 -0.46, 1.02  0.25 -0.51, 1.01 
 Knee -0.02 -0.74, 0.71  -0.11 -0.87, 0.65 
 Foot 0.23 -0.50, 0.95  0.23 -0.50, 0.96 
 Upper limb -0.07 -0.33, 0.19  -0.19 -0.55, 0.16 
 Lower limb 0.10 -0.27, 0.48  0.10 -0.23, 0.43 
Bold denotes statistically significant result. β regression coefficient; CI confidence interval; ROA 
radiographic osteoarthritis; Ref reference group; 
†Adjusted for age, sex, body mass index, physical activity, any pain medication, baseline cartilage 
volume, cartilage defects and bone marrow lesions; 
‡Further adjusted for pain at other sites.  
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8.4 Discussion 
This longitudinal study shows that greater number of painful sites is associated with 
knee cartilage volume loss, especially in those without ROA. These relationships 
persisted after adjustment for age, sex, BMI, physical activity, pain medication, and 
knee structural abnormalities at the lateral and total tibiofemoral compartments, 
suggesting that MSP may be an early marker of more rapid knee cartilage loss. The 
underlying mechanisms for this association are uncertain, but could include systemic, 
central or genetic factors. To our knowledge, this is the first to investigate the 
prospective relationship between MSP and cartilage volume loss.  
The high prevalence of MSP (>2 sites) found in this study is similar to reported 
prevalence in previous studies [311, 315, 332, 361], despite differences in the 
methods of assessing pain and the number of pain sites. This finding corroborates the 
evidence that MSP is very common in the older general population. Consistent with 
some previous studies (but not all) [245, 255], knee pain was not found to be 
associated with high rates of cartilage volume loss in any compartments, whereas 
these findings differ from some of previous studies which identified the relationship 
between knee pain and cartilage volume loss [252, 349-351]. These discordances 
could be attributed to the differences in characteristics of population included, follow-
up time period, and measurement and/or definition of knee pain.  
The present study found that increasing number of painful sites is associated with 
greater cartilage volume loss. One possible explanation for this link is the 
involvement of systemic inflammation which have been shown to be a critical 
contribution to both pain [355] and OA pathogenesis [362]. In the process of 
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inflammation, inflammatory factors are released, such as cytokines, chemokines, 
prostanoids, proteolytic enzymes and nerve and vascular growth factors, which can 
activate peripheral nociceptors, thereby leading to peripheral sensitisation and 
hyperexcitability of dorsal horn transmission neurons in the central nervous system 
(central sensitisation) [95, 363]. These inflammatory factors are also associated with 
increased cartilage turnover and matrix degradation [364]. Furthermore, heightened 
pain sensitivity can contribute to increased level of inflammatory factors releases, 
thus creating a cycle of inflammation, high pain sensitivity and pain severity [353]. 
Based upon this evidence, it is plausible that people reporting pain at greater numbers 
of painful sites are more likely to have a higher level of systemic inflammation, 
leading to more loss of cartilage volume.   
Overweight or obesity is widely considered as an important risk factor for developing 
pain [95, 365]. Potential mechanisms include increased physical loading as well as 
systemic inflammation. Increasingly, evidence supports a more important role for 
systemic inflammation rather than physical loading, as the mechanical effect of 
overloading is insufficient to explaining pain at non-weight bearing joint, such as 
hand pain [341]. Those with greater numbers of painful sites were heavier in this 
study, supporting this hypothesis. However, the relationship between number of 
painful sites and knee cartilage volume loss did not change after adjustment for BMI, 
suggesting that this relationship is independent of BMI. Moreover, we found that 
cartilage volume loss is associated with upper limb pain rather than lower limb pain. 
This further supports that it is not simply due to loading.  
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Previous studies demonstrate a considerable genetic influence on pain. Genetic 
components can account for approximately 50% heritability estimates for different 
pain traits in twin studies [276]. Candidate gene studies have identified multiple genes 
associated with pain sensitivity [278-280]. Furthermore, evidence suggests that 
peripheral/central nervous system sensitisation and multiple biologic/psychological 
processes are shared pain mechanisms in multiple conditions including back pain, 
neck pain, shoulder pain, OA and CWP, etc [366, 367]  and are strongly affected by 
underlying genetic factors [341]. A recent twin study also demonstrates a single 
underlying genetic factor which can explain pain reporting at different sites [368], and 
Malkin et al. reports that back pain and CWP are linked by shared genetic factors 
[369]. This indicates that back pain/upper limb pain may be a group with CWP, and 
could explain why back pain/upper limb pain are more predictive of cartilage volume 
loss. In the current study, we found that cartilage volume loss is greater in those with 
pain at multiple sites. It is likely that MSP in older people represents generalised OA 
which has a strong genetic component implicated in its’ pathogenesis [370]. 
Therefore, combined with the finding that cartilage volume loss is greater in those 
with MSP, these studies imply that genetic factors may have a crucial role in 
determining the additive effects of MSP. Nonetheless, it is currently unknown which 
genes explain a larger proportion of the susceptibility to pain or cartilage loss, and 
whether genes linked to cartilage loss have any role in the regulation of pain, although 
several articular cartilage related genes were found to be associated with characterised 
pain phenotypes [371].  
The present study failed to detect any significant association between cartilage 
volume loss and MSP in people with ROA, which could be explained by the stage of 
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disease. Radiographically evident changes represent later stage OA, and therefore 
individuals with ROA would lose cartilage volume faster than those without ROA 
[372]. This is supported by our finding that people without ROA have more cartilage 
volume at baseline (data not shown). Conceivably, this finding may not only have 
great practical implications for early diagnosis, but also highlights the importance of 
treatment targeted at MSP as it might have beneficial effects to limit progression to 
end-stage disease. Also, our results showed a tendency towards increased cartilage 
volume loss at the medial tibiofemoral compartment, although it did not show a 
statistically significant association. The reason for this is unclear. This could be 
attributable to more mechanical effects on medial compartment, subsequently, 
contributing to less medial tibiofemoral cartilage volume at baseline compared with 
lateral compartment, so there were not too much room to move on the scale 
theoretically.  
The strengths of the current study are the longitudinal study design, the relatively 
large sample size and the objectively measured outcome (cartilage volume loss, as 
measured by MRI). Some potential limitations in this study have to be considered 
when interpreting these results. These include the self-reported binary nature of the 
assessments of pain [95],  which did not allow investigation of any effect of pain 
intensity on cartilage volume loss; therefore, to what extent more severe pain is 
associated with cartilage volume loss is still unclear. Furthermore, pain may result 
from other musculoskeletal diseases; however, we have not screened for these 
conditions. Second, we do not have images of other sites to know whether they have 
any site pathology, which might explain localized pain. Lastly, a possible problem 
with this study was loss to follow-up which may bias our results as people with more 
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painful sites were more likely to have lower physical function which may 
underestimate the association. Also, for the current study, repeat MRI scans at 2.6 
years were only available in a subset of the TASOAC study; however, there were no 
significant differences between the participants included in this study and the rest of 
the cohort in terms of in demographics, physical activity, ROA and the number of 
painful sites, apart from a higher prevalence of medial tibiofemoral cartilage defects 
in those not included, and the results did not alter after using inverse probability 
weighting, indicating that our results are robust. 
In conclusion, the presence of MSP independently predicts knee cartilage volume 
loss, especially in people without knee OA, suggesting that widespread pain may be 
an early marker of more rapid knee cartilage loss in those without ROA. The 
underlying mechanism is unclear, but it is independent of anthropometrics, physical 
activity and knee structural abnormalities, possibly mediated by systemic, central or 
genetic factors. More research is needed to demonstrate the non-conventional role of 
pain at other sites in early stage of knee OA, thereby possibly facilitating the 
development of disease-modifying interventions. 
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9.1 Summary 
As mentioned above, OA is the most common form of arthritis [60]. It is a leading 
cause of pain and disability accompanied by functional limitation and reduced quality 
of life. OA is predicted to become more prevalent as expected lifespan and rate of 
obesity increase, resulting in an even larger personal, social and economic burden [2]. 
Despite this, currently, there is no cure for OA and treatment mostly focuses on pain 
relief and functional improvement for the affected joints [109, 373]. Therefore, the 
development of prevention strategies appears to be of particular importance in the 
prevention of OA [374]. However, there are some obstacles in current OA research 
and clinical strategies which primarily utilise radiography to study, diagnose and treat 
the disease. This evaluation most likely reflects later disease with irreversible 
structural changes, which might be a key reason to explain why few interventions 
have been shown to be effective in both prevention and treatment; we, therefore, need 
to focus on an earlier stage of the disease when there are reversible structural changes 
[57]. This will enable us to identify risk factors or biomarkers for early stages of the 
disease and thus help prevent and understand the pathogenesis of how risk factors 
confer the development and progression of OA and pain it causes. OA is a highly 
heterogeneous disease with a considerable number of risk factors interacting with 
each other. Two important risk factors, which may have a crucial role in the 
identification of ‘at risk’ patients and the management of OA, are genetic factors and 
obesity. This thesis has investigated the role of genetic factors and/or obesity in the 
early structural changes on MRI and pain, with some novel and important findings, as 
summarised below. 
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Chapter 4 examined the associations between family history of knee OA and knee 
structural changes over 8-10 years. Offspring having at least one parent with TKR for 
severe primary knee OA were found to have a greater increase in cartilage defects, 
meniscal extrusion and tears in the medial tibiofemoral but not lateral compartment 
than controls with no family history of knee OA. BMLs were not different between 
offspring and controls. Furthermore, family history of knee OA was associated with 
increased risk of worsening cartilage defects, meniscal extrusion and tears before and 
after adjustment for potential confounders, suggesting that the effects of genetic 
factors are pleiotropic being associated with the progression of multiple structural 
abnormalities, and thus supporting the notion that genetic factors may influence the 
tissue of entire joint other than cartilage. These associations were only seen at the 
medial compartment suggesting site-specific effects of genetic factors. There was no 
significant association for BMLs, suggesting a greater environmental effect influence 
changes in BMLs; which implies they may be modifiable. Although multiple 
environmental factors have been adjusted in this study, we were unable to rule out 
and calculate the weight of environmental factors in the progression of cartilage 
defects and meniscal pathology. Whilst cartilage preservation and repair have become 
realistic, recent developments in the tissue engineering research, in particular stem-
cell-based therapy, have achieved functional replacement of articular cartilage, 
implying that cartilage damage is modifiable despite genetic control [375]. 
Chapter 5 explored the associations of weight with knee cartilage volume/defects 
over 10 years in offspring and controls. This long-term follow-up study extends prior 
observations and provides a strong support for the deleterious effects of increasing 
weight on the cartilage damage and loss. Increasing weight was negatively associated 
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with cartilage volume and the presence of cartilage defects in offspring, but no 
significant associations were found in controls. Interestingly, the effect sizes of 
weight on both cartilage defects and volume were significantly and consistently 
higher than that in controls. This most likely indicates gene-environment interaction 
with regard to overweight/obesity in the pathogenesis of early stage of the disease. 
Our study also reflects a role of age mediating these associations based on the 
findings of a significant interaction between time and weight on lateral cartilage 
volume, suggesting aging makes the knee joint more susceptible to the effects of 
weight. Although the association between weight and lateral cartilage volume did not 
reach statistical significance in offspring with an adverse effect of weight gain on 
cartilage volume, a significant interaction between weight and time on lateral 
cartilage volume indicates that a longer time-frame follow-up may be needed to detect 
a significant association in this relatively younger population.  
Chapter 6 described the prevalence of knee pain and its change between offspring 
and controls, and examined the associations between family history of knee OA and 
change in knee pain measured by WOMAC over 8 years. Knee pain was more 
prevalent in offspring than in controls at baseline and 10 years. Also, offspring had 
higher scores in total pain and each subscale at both 2 years and 10 years, although 
some scores at 2 years were not statistically significant. In relative to controls, greater 
changes in pain scores and a high proportion of worsening knee pain (≥1) were 
observed in offspring. Offspring were found to have about two-fold higher risk of 
worsening total knee pain and each subscale, and these associations were independent 
of structural abnormalities and potential confounders, implying that genetic 
components may be implicated in the pathogenesis of pain, and the genesis of pain 
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may result from factors outside the joint possibly attributable to difference in pain 
processing. 
Chapter 7 described the prevalence of MSP and investigated the longitudinal 
associations of fat mass, FMI and BMI with MSP as well as site-specific pain over 
5.1 years in a population-based study of older adults. This study further corroborates 
that MSP is extremely prevalent in community-based older population. This is the 
first study to show longitudinal associations between fat mass and MSP, finding that 
fat mass was associated with MSP and this association was independent of 
demographic factors, physical activity, psychological health, education level and 
employment. This suggests an important role of fat mass in the pathogenesis of MSP. 
Fat mass, FMI and BMI were found not only to associate with pain at weight-bearing 
sites (hips, knees and feet), but with hand pain, implying that the underlying 
mechanisms by which obesity contributes to MSP may be due to both physical 
loading and systemic inflammatory factors, but the latter one appears to be more 
important as systemic inflammation has been recognised as an important factor in 
driving the development of peripheral and central sensitisation, thereby leading to 
pain at multiple sites. Given that MSP may reflect high systemic inflammation and 
pain processing; this prompted the work done in Chapter 8 investigating the 
association between MSP and the hallmark of knee OA (cartilage volume loss). 
Chapter 8 examined whether pain at multiple sites predicts knee cartilage volume 
loss over 2.6 years and explored the potential mechanisms. There was a tendency 
towards an increase of cartilage volume loss in medial, lateral and total tibiofemoral 
compartments as number of painful site increased. These relationships persisted for 
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lateral and total tibiofemoral cartilage volume loss after adjustment for potential 
confounders suggesting that MSP is associated with more cartilage volume loss. 
Notably, these positive and dose-response relationships between number of painful 
sites and cartilage volume loss were only seen for those without radiographic OA, this 
highlights the predictive role of number of painful sites in the early pathogenesis of 
knee OA. The potential mechanism mediating these relationships more likely involve 
systemic inflammation because of the findings that cartilage volume loss was 
associated with upper limb pain (hand, shoulder and back), but not pain at lower limb 
sites as well as other mechanisms such as central and genetic factors. 
To sum up, this series of related analyses based on two prospective studies of younger 
and older population shed light on the role of genetic and systemic inflammatory 
factors in the pathogenesis of OA and pain. These results not only highlight the 
possibility of identifying ‘at risk’ patients earlier, but, most importantly, offer an 
opportunity to develop therapeutic approaches targeting those at high risk of the 
disease and its symptom. 
9.2 Implication and Future directions 
There are some very novel findings from this thesis based on two prospective studies 
of younger and older population which have great significance for the development of 
prevention and treatment strategies for OA and its symptoms. Chapter 4 and 
Chapter 6 examined the role of family history of knee OA in the progression of early 
knee structural changes and knee pain, suggesting a possible role of genetic 
components in the early stage of the disease and pain. Currently, phenotype 
standardisation remains a question to be solved in the genetic studies of OA, although 
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a more homogenous phenotype for OA has been examined in which the cases were 
defined as TJR only [376]. It is hoped that genetic studies focus on endophenotypes 
that are measureable, underlying and intermediate biomarkers with a closer and direct 
relationships to the disease may be of particular advantage in such a heterogeneous 
condition [377]. As with other complex diseases, endophenotypes in OA are 
attracting increased attentions to unravel genetic contribution to OA [131]. An 
example in OA is the use of joint space width on radiographs as a surrogate for 
cartilage thickness in which DOTL1 locus was identified associated with cartilage 
thickness [378, 379]. Cartilage defects and meniscal pathology have been associated 
with knee OA [26, 380], and our results have shown that these structures are under 
genetic control. Given these, these early structures could be promising and ideal 
endophenotypes to be studied in the future OA genetic studies [133]. In contrast, 
progression in BMLs is more likely to be affected by environmental factors, 
suggesting that BMLs may be more amenable to modification. This is supported by a 
clinical trial from our group that found use of a single dose of zoledronic acid (5 mg) 
can significantly reduce BML size compared to placebo after six months [381]. The 
influence of genetic factors on knee pain also found in the Chapter 6 suggests that 
pain may represent a crucial phenotype related to OA to study, but limited studies are 
available to date with only one GWAS which identified genes to link CWP [177]. 
Identification of risk loci implicated in the pathological process of OA and pain may 
be clinically beneficial for the development of novel therapeutic approaches. 
Individuals with family history of OA appear to develop the disease and progress 
earlier in the Chapter 4. This implies that those with OA family history may be of 
great utility in the development of biomarker of early OA and the design of clinical 
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trials to maximize the differentiation of interventions and placebo groups. Chapter 6 
showed that the associations between family history of OA and worsening knee pain 
are independent of structural abnormalities, suggesting that structural lesions may not 
be major elements for developing and maintaining pain, possibly due to the 
involvement of peripheral and central nervous system sensitization. It is therefore 
suggested that the limitations of use of analgesics targeting peripheral knee joint alone 
in the clinical setting and structural modification may not be sufficient in the 
management of OA-related pain. Agents with central action targeting pain 
mechanisms are needed to be further developed and tested in future studies. Also, 
future studies on why the correlation between structures and pain is poor are 
warranted, for example, studies using brain positron emission tomography (PET) and 
functional MRI may facilitate our understanding about importance of alterations in 
brain functional connectivity, affective and motivational aspects of pain, and how 
systemic inflammation induced by tissue damage (peripheral stimuli) leads to the 
development of central sensitization [382]. 
Chapter 5 demonstrated greater effect sizes for the associations between weight and 
knee cartilage loss and defects in the offspring than that in controls, suggesting gene-
environment interaction with regard to obesity in the pathogenesis of knee OA. Our 
results highlight that achievement and maintenance of a healthy weight are of great 
importance to avoid early stage of the disease, particularly in those with family 
history of OA. There is evidence to suggest that modest weight loss in early stage of 
disease process appears to be a more effective method in decreasing the incidence and 
progression of symptomatic OA than in the later stage of the disease [383]. Therefore, 
early screening of family history combined with an important risk factor (obesity) 
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could be the most effective way for identifying individuals at high risk and open up 
an opportunity to prevent and treat the disease earlier. For instance, consideration 
should be given in monitoring weight in obese individuals if there is a positive OA 
family history. Those individuals at high risk should be encouraged to avoid weight 
gain through participation in physical activity, healthy dietary intake. Bariatric 
surgery is the most effective treatment for weight loss in the short-term [384]; 
therefore, surgical treatments may significantly reduce the risk of OA in obese 
individuals with family history, this could be trialed. Furthermore, the impact of 
weight loss and the efficacy of disease modifying OA drug on knee structures warrant 
further investigation in the subgroup of individuals most at high-risk. Taken together, 
the findings from Chapter 4, 5 and 6 that environmental factors (obesity) interact 
with genetic factors to increase the risk of early structural changes and symptoms, and 
BMLs are more likely to be affected by environmental factors highlight the 
importance of measurement of inflammatory marker (such as CRP) in this genetically 
loaded cohort. Future research in this field is needed, and thus allow to develop 
effective prevention and intervention strategies. 
Not only does weight loss have a beneficial effect on the prevention of early stage of 
OA, but is beneficial for pain management. Chapter 7 found that fat mass was 
associated with MSP, lower limb and hand pain, suggesting that other than physical 
loading, systemic inflammatory factors may have an important role in the 
pathogenesis of pain. Hence, weight management and maintenance should be 
emphasized across population groups to achieve a public health goal. Exercise and 
healthy diet should be advocated; however, which approaches can effectively achieve 
weight loss and maintain weight remains challenging. Systemic inflammatory factors 
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present the potential target for intervention, so treatments aimed at reducing the level 
of inflammation and blocking biosynthesis of adiposity may have a role in alleviating 
pain. Further studies are needed to investigate which mechanisms (physical loading or 
systemic inflammation) play more important role in the pathogenesis of pain and 
which inflammatory markers directly participate in pain generation. 
Chapter 8 supports a role of systemic factors in the cartilage volume loss. Number of 
painful sites was associated with cartilage volume loss over 2.6 years before and after 
adjusting for possible confounding factors, suggesting that there may be a role of 
systemic inflammation as a mediator of this effect affecting the progression of knee 
OA. A systematic review from our group have concluded that serum CRP is 
significantly associated with symptoms rather than with ROA [385]. Also Haugen et 
al. [386] found that symptomatic hand OA, but not radiographic hand OA is related to 
elevated risk of coronary heart disease events, indicating pain may be a marker of 
systemic inflammation. There have been conflicting results regarding the relationship 
between knee pain alone and knee cartilage volume loss; surprisingly, a dose-
response relationship between number of painful sites and cartilage volume loss was 
observed. Given this, those with greater number of painful sites may have a higher 
level of systemic inflammation, and other than affected joint, pain at other sites 
should be taken into account in the OA research and clinical trial. Interestingly, the 
associations of number of painful sites and cartilage volume loss were stronger in 
those without radiographic knee OA than with radiographic knee OA. This, therefore, 
not only presents the possible opportunity for the early diagnosis of knee OA through 
simply counting the number of pain sites, but may allow for the development of 
therapeutic strategies through targeting MSP with anti-inflammatory and centrally-
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acted drugs, which would be more relevant to the treatment of progression of OA. 
Despite no clinical trial investigating this directly, several previous studies seem to 
support this. A multicentre clinical trial [387] shows that licofelone, an analgesic and 
an anti-inflammatory, can significantly reduce cartilage volume loss over time in 
patients with knee OA. Moreover, it has been reported that long-term use of NSAIDs 
was associated with less changes in joint space width values compared to nonusers 
[388]. It is, therefore, possible that treating MSP through anti-inflammatory pathway 
may lead to a reduction of the progression of OA, and further clinical trials on MSP 
are required. 
In conclusion, these analyses of data from two prospective cohort studies have 
demonstrated that genetic effects, environmental effects and their interactions with 
each other play an important role in the pathogenesis of early stage of knee OA and 
its symptoms (pain). The findings from this thesis may enable the early identification 
of high-risk groups, and allow for the identification of novel treatment strategies of 
early stage of the disease. Future research is needed to investigate screening family 
history of OA in the prevention of OA and to better define a definite relationship 
between systemic inflammation and pain in OA. 
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